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ABSTRACT 
Although the rabbit brain, in particular the basal forebrain cholinergic system, has 
become a common model for neuropathological changes associated with Alzheimer's disease, 
detailed neuroanatomical studies on the morphological organization of basal forebrain cho-
linergic nuclei and on their output pathways are still awaited. Therefore, we performed 
quantitative choline acetyltransferase (ChAT) immunocytochemistry to localize major cho-
linergic nuclei and to determine the number of respective cholinergic neurons in the rabbit 
forebrain. The density of ChAT-immunoreactive terminals in layer V of distinct neocortical 
territories and in hippocampal subfields was also measured. Another cholinergic marker, the 
low-affinity neurotrophin receptor (p75NTR), was also employed to identify subsets of cholin-
ergic neurons. Double-immunofluorescence labeling of ChAT and p75N T R , calbindin D-28k 
(CB), parvalbumin, calretinin, neuronal nitric oxide synthase (nNOS), tyrosine hydroxylase, 
or substance P was used to elucidate the neuroanatomical borders of cholinergic nuclei and 
to analyze the neurochemical complexity of cholinergic cell populations. Cholinergic projec-
tion neurons with heterogeneous densities were found in the medial septum, vertical and 
horizontal diagonal bands of Broca, ventral pallidum, and magnocellular nucleus basalis 
(MBN)/substantia innominata (SI) complex; cholinergic interneurons were observed in the 
caudate nucleus, putamen, accumbens nucleus, and olfactory tubercule, whereas the globus 
pallidus was devoid of cholinergic nerve cells. Cholinergic interneurons were frequently 
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present in the hippocampus and to a lesser extent in cerebral cortex. Cholinergic projection 
neurons, except those localized in SI, abundantly expressed p75NTR, and a subset of cholin-
ergic neurons in posterior MBN was immunoreactive for CB and nNOS. A strict laminar 
distribution pattern of cholinergic terminals was recorded both in the cerebral cortex and in 
CA1-CA3 and dentate gyrus of the hippocampus. In summary, the structural organization 
and chemoarchitecture of rabbit basal forebrain may be considered as a transition between 
that of rodents and that of primates. J . Comp. Neurol. 460:597-611, 2003. 
O 2003 Wiley-Liss, Inc. 
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microscopy; p75 low-affinity neurotrophin receptor; mapping 
The basal forebrain (BFB) cholinergic system is in-
volved in the regulation of a broad range of brain functions 
(Dunnett et al., 1991; Rasmusson, 2000; Semba, 2000). In 
particular, tonic cholinergic input to the cerebral cortex 
and hippocampus contributes to learning processes and 
memory consolidation and retrieval (Everitt and Bobbins, 
1997; Sarter and Bruno, 1999, Rasmusson, 2000). In ad-
dition, cholinergic neurons of the BFB also participate in 
the control of attention (Everitt and Robbins, 1997) as well 
as in the sleep/wake cycle (Semba, 2000). Multiple levels 
of evidence from both human and animal studies indicate 
that damage to cholinergic projection systems correlates 
with the development of cognitive impairment (Schliebs, 
1998; Iraizoz et al., 1999; Harkany et al., 2000; Berger-
Sweeney et al., 2001). Therefore, a causal relationship 
between cholinergic dysfunction and the progression of 
memory deficit in neurodegenerative disorders, such as 
Alzheimer's disease (AD), has been postulated. 
In mammalian species investigated so far, the BFB 
cholinergic system consists of several interrelated nuclei 
that correspond with the Chl-Ch4 regions as designated 
by Mesulam et al. (1983a, b). In general terms, cholinergic 
magnocellular projection neurons of the medial septum 
(MS) and vertical diagonal band of Broca (VDB) form the 
Chi and Ch2 subdivisions, respectively; the horizontal 
Abbreviations 
AcSh shell of nucleus accumbens 
AD Alzheimer's disease 
BFB basal forebrain 
CB calbindin D-28k 
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ir immunoreactive 
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MS medial septum 
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PB phosphate buffer 
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Pu putamen 
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TBS Tris-buffered saline 
TBS-BSA Tris-buffered saline containing 2% bovine serum albumin 
TH tyrosine-hydroxylase 
VDB vertical diagonal band of Broca 
VP ventral pallidum 
diagonal band of Broca (HDB) corresponds well with the 
Ch3 region, and cholinergic neurons situated in the ven-
tral pallidum (VP), medullaiy laminae of the globus pal-
lidus (GP), and magnocellular nucleus basalis (also 
termed nucleus basalis of Meynert for human)/substantia 
innominata complex (MBN/SI) have been regarded as ma-
jor constituents of the Ch4 subdivision. Cholinergic pro-
jection neurons provide topologically strictly defined pro-
jections to remote areas, such as the cerebral cortex, 
hippocampus, thalamic nuclei, olfactoiy bulb, and amyg-
dala (Armstrong et al., 1983; Mesulam et al., 1983b; 
Saper, 1984; Kása, 1986; Eckenstein et al., 1988; Brück-
ner et al., 1992; Semba, 2000). Tract-tracing studies dem-
onstrated that the MS and VDB are major sources of 
cholinergic terminals in the hippocampus; anterior, inter-
mediate, and posterior subregions of the MBN innervate 
distinct areas of the cortical mantle, whereas cholinergic 
neurons of the VP and SI project to the amygdala (Mesu-
lam et al., 1983b; Baisden et al., 1984; Rye et al., 1984; 
Ingham et al., 1985; Luiten et al., 1987). In their target 
regions, cholinergic fibers terminate on both excitatory 
(e.g., glutamatergic) and inhibitory (e.g., -y-aminobutyric 
acidergic) neurons, where acetylcholine-mediated modula-
tion of the firing activity of target cells provides the ana-
tomical substrate for the cholinergic control of a wide 
range of brain functions (Freund and Antal, 1988; Ras-
musson, 2000). In addition to cholinergic projection neu-
rons, cholinergic interneurons have frequently been found 
in striatal regions, the cerebral cortex (Sofroniew et al., 
1982; Houser et al., 1985), and the hippocampus of differ-
ent mammalian species (Freund and Buzsáki, 1996; 
Frotscher et al., 2000). 
Structural organization of cholinergic BFB nuclei and 
the topography of their projections have been the subjects 
of investigations in several mammalian species, including 
rat (Bigl et al., 1982; Armstrong et al., 1983; Mesulam et 
al., 1983a), cat (Kimura et al., 1981), rhesus monkey (Me-
sulam et al., 1983a; Geula et al., 1993), and human (Geula 
et al., 1993). Although major neuroanatomical character-
istics of cholinergic BFB nuclei are apparently similar in 
the mammalian species studied, important species-
specific differences were also identified (Geula et al., 
1993). These include, for example, the relative reduction 
of MS and VDB; appearance of septum pellucidum; topo-
logical organization of the VP and the MBN/SI complex; 
and localization of the capsulae interna, externa, and ex-
trema. From a neurochemical point of view, 1) selective 
expression of the low-affinity neurotrophin receptor p75 
(p^*1™) j n cholinergic neurons of all mammalian species 
(Mufson et al., 1989; Maclean et al., 1997; Tremere et al., 
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2000); 2) the presence of calbindin D-28k (CB) in cholin-
ergic neurons of primates, including humans (Chang and 
Kuo, 1991; Côté and Parent, 1992; Geula et al., 1993; 
Ichitani et al., 1993; Härtig et al., 2002); and 3) (»expres-
sion of neuronal (constitutive) nitric oxide synthase 
(nNOS) in subsets of rat BFB cholinergic neurons 
(Schober et al., 1989; Brauer et al., 1991; Geula et al., 
1993) illustrate profound phylogenetic differences that 
may substantially influence the sensitivity of cholinergic 
neurons of different mammalian species to aging and to 
experimental manipulations. 
Recent experimental data indicate that the rabbit brain 
might be in several respects appropriate for modeling 
multiple neurochemical characteristics of AD, inasmuch 
as subcortical denervation by means of ME20.4-saporin 
induced selective cholinergic immunolesions (Beach et al., 
2000), and feeding with diets containing high cholesterol 
concentrations was shown to trigger the formation of se-
nile plaque-like ß-amyloid deposits in the rabbit cerebral 
cortex (Sparks et al., 1994, 1995, 2000). In spite of the 
growing interest in using the rabbit for modeling cholin-
ergic dysfunction, detailed neuroanatomical studies on the 
organization of cholinergic components of the rabbit BFB 
are still lacking. In fact, only a few neuroanatomical de-
scriptions based on classical histological techniques (Win-
kler and Potter, 1911; Monnier and Gangloff, 1961; Urban 
and Richard, 1972) and immunohistochemical studies 
(McGeer et al., 1974; Kan et al., 1978; Chao et al., 1982; 
Baisden et al., 1984) have addressed the localization of 
cholinergic nuclei in rabbit brain. These studies fell short, 
however, because of either the only superficial localization 
of cholinergic nuclei or partly insufficient choline acetyl-
transferase (ChAT; EC 3.2.1.6) immunolabeling (as de-
scribed in detail by Rossier, 1981). In the present study, 
therefore, we performed sensitive immunoperoxidase la-
beling of ChAT and p75NTR on serial sections spanning all 
major cholinergic BFB nuclei as well as cerebral cortical 
and dorsal hippocampal projection areas to map their 
structural organization and to measure the number and 
density of cholinergic nerve cells and of their cortical and 
hippocampal projections. Moreover, additional series of 
sections were double-labeled for ChAT and p75NTR, the 
calcium-binding proteins parvalbumin (PV), calretinin 
(CR), CB, nNOS, tyrosine hydroxylase (TH), or substance 
P (SP) to identify the neurochemical heterogeneity and 
spatial relationships of cholinergic BFB neuron popula-
tions. Although our primary aim was to investigate the 
Chl-Ch4 areas, we also studied the striatal regions, 
where large cholinergic interneurons exhibit some differ-
ences in their p75NT expression in some animal species 
investigated to date (Kokaia et al., 1998; Ferreira et al., 
2001). 
MATERIALS AND METHODS 
Animals, perfusion, and sectioning 
New Zealand white rabbits of both sexes (n = 7,2.3-5.1 
kg, 4-15 months of age) were used in this study. The 
animals were deeply anesthetized with a mixture of ket-
amine (50 mg/kg body weight; Exalgon; Merck, Hallberg-
moos, Germany) and xylazine (4 mg/kg body weight; 
Rompun; Bayer AG, Leverkusen, Germany). Subse-
quently, the rabbits were transcardially perfused with 800 
ml of 4% paraformaldehyde containing 0.1% glutaralde-
hyde in phosphate-buffer (PB; 0.1 M, pH 7.4) that was 
preceded by a prerinse with ice-cold physiological saline 
(150 ml). Whole brains were removed from the skull, di-
vided into fore- and hindbrain regions, and postfixed in 4% 
paraformaldehyde overnight. All efforts were made to 
minimize the number of animals and their suffering 
throughout the perfusion procedure. Their care and treat-
ment were in accordance with European Communities 
Council Directive 86/609/EEC and were approved by the 
Local Ethical Committee of the University of Leipzig 
(TW-Nr. 15/00). 
For cryoprotection, forebrain samples were equilibrated 
in 30% sucrose in PB for at least 48 hours. Thirty-
micrometer thick coronal sections were cut on a freezing 
microtome and collected individually in Tris-buffered sa-
line (TBS; 0.1 M, pH 7.4). Sectioning started at the ante-
rior pole of the MS and spanned the entire BFB, including 
the caudal pole of the MBN/SI complex, yielding about 250 
sections in each individual case. To ensure standard cross-
sectional distances throughout the quantification proce-
dures, each sixth section was immunolabeled for ChAT; all 
consecutive sections were processed for p75NTR (both with 
nickel-enhanced 3,3'-diaminobenzidine as chromogen), 
whereas the successive series was used for Nissl staining. 
A fourth series of sections was applied to the immunoflu-
orescence double labeling of ChAT and p75NTR and was 
pretreated with Sudan black B according to Schnell et al. 
(1999) to quench autofluorescence of the tissue and to 
reveal the myelination of fibers. To assess quantitatively 
the possible colocalization of CB and nNOS in cholinergic 
neurons, the fifth and sixth series of sections in two male 
and one female rabbits were used for double-
immunofluorescence detection of CB/ChAT and nNOS/ 
ChAT, respectively. For the carbocyanine (Cy) double-
fluorescence staining of ChAT and a panel of additional 
neuronal markers (see Table 1), sections from the fifth 
series of one male rabbit and selected sections from two 
female animals were used without Sudan black B pre-
treatment. According to this sampling protocol, the cross-
sectional distance amounted to 180 p.m. 
Immunohistochemical procedures 
All immunohistochemical methods were performed on 
free-floating sections. Before immunoperoxidase staining, 
endogenous tissue peroxidase activity was abolished by 
treatment with 0.6% H 20 2 in TBS for 30 minutes. For the 
immunoperoxidase labeling of ChAT, sections were then 
preincubated in 5% normal donkey serum (Jackson Im-
munoresearch, West Grove, PA) in TBS containing 0.3% 
Triton X-100 for 1 hour. Subsequently, tissue samples 
were incubated in affinity-purified goat anti-ChAT (Li and 
Furness, 1998; Reiche and Schemann, 1999; Chemicon 
International, Hofheim, Germany; 1:100 in TBS contain-
ing 0.3% Triton X-100 and 5% normal donkey serum) for 
16 hours at room temperature. Subsequently, sections 
were thoroughly rinsed and exposed to biotinylated don-
key anti-sheep IgG [highly cross-reacting with goat IgG 
(Jackson Immunoresearch); 1:500 in TBS containing 2% 
bovine serum albumin (TBS-BSA)] for 1 hour. Finally, 
sections were processed with preformed complexes of 
streptavidin and biotinylated peroxidase and stained with 
nickel-enhanced 3,3'-diaminobenzidine as chromogen 
(Hartig et al., 1995). 
For the immunodetection of p75NTR, nonspecific binding 
sites were blocked in 5% normal goat serum (Jackson 
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TABLE 1. List of Markers Used for Double-Immunofluorescence Labeling1 
Marker Host Dilution Source 
Fluorochromated 
secondary antibody Reference 
Choline acctyltranafcrase Goat 1:25 Chcmicon, Hofhcim, Germany Cy2 donkey anti-goat Li and Furncss, 1998 
1:50 Cy3 donkey anti-goat Reiche and Schcmann, 1999 
p75 Ncurotrophin receptor Mouse 1:2 Dr. A. Fine, Halifax, NS, Canada Cy3 donkey anti-mouse Ross et al-, 1984 
(clone ME 20.4) 
Calbindin D-28k Mouse 1:200 Sigma, Deisenhofen, Germany Cy2 donkey anti-mouse Cclio et al-, 1990 
(clone CL-300) 
Calrctinin Rabbit 1:300 SWnnt, Bcllinzona, Switzerland Cy2 donkey anti-rabbit Schwaller et al., 1993 
Parvalbumin Mouse 1:300 SWant, Bcllinzona, Switzerland Cy2 donkey anti-mouse Cclio et al., 1988 
(clone PA-235) 
Nitric oxide synthase, neuronal Rabbit 1:200 Laboscrv, Gicsscn, Germany Cy2 donkey anti-rabbit Ahn et al., 1993 
Substance P Rabbit 1:1,000 DiaSorin, Stillwater, MN Cy3 donkey anti-rabbit Gall, 1988 
Tyrosine hydroxylase Rabbit 1:250 Chemicon, Hofheim, Germany Cy3 donkey anti-rabbit Haycock, 1987 
'Panel of antibodies used to determine the neurochemical heterogeneity of cholinergic neurons in rabbit basal forobrain. Staining methods arc described in detail in Materials and 
Methods. Cy, carbocyanino. 
Immunoresearch) in TBS containing 0.3% Triton X-100 
for 1 hour, followed by incubation of the sections in mono-
clonal mouse anti-p75NTR antibody [clone ME 20.4, 1:5 
(Ross et al., 1984); donated by Dr. A. Fine] in the blocking 
solution overnight. After extensive rinsing, sections were 
reacted with biotinylated goat anti-mouse IgG (Jackson 
Immunoresearch; 2.5 |xg/ml in TBS-BSA) for 1 hour. 
Thereafter, tissue samples were processed according to a 
visualization protocol identical to that described for the 
immunodetection of ChAT (Hartig et al., 1995). 
For the immunofluorescence double labeling of ChAT 
and other markers, sections were preincubated in TBS 
containing 0.3% Triton X-100 and 5% normal donkey se-
rum for 1 hour. Sections were then exposed to a mixture 
containing both goat anti-ChAT and one of the primary 
mouse or rabbit antibodies listed in Table 1 in TBS con-
taining 0.3% Triton X-100 and 5% normal donkey serum 
for 16 hours. The goat anti-ChAT antibody was applied in 
a 1:25 dilution and subsequently visualized by Cy2-
conjugated donkey anti-goat IgG combined with the im-
munolabeling of p75NTR, SP, and TH with Cy3-tagged 
secondary antibodies. In contrast, goat anti-ChAT anti-
body was used at a dilution of 1:50 and localized with 
Cy3-tagged donkey anti-goat IgG when CB, CR, PV, and 
nNOS were simultaneously revealed with Cy2 immuno-
staining (Table 1). All secondary antibodies were applied 
at a concentration of 20 (ig/ml TBS-BSA for 1 hour and 
were obtained at the highest available purity (Jackson 
Immunoresearch). 
Omission of the primary antibodies in control experi-
ments caused the absence of any cellular staining. More-
over, switching of the fluorophores for the detection of 
ChAT and any other relevant markers resulted in labeling 
patterns identical to those yielded in the serial staining 
experiments. After the histochemical procedures, sections 
were extensively washed in TBS, dipped in distilled water, 
mounted on fluorescence-free slides, air dried, and cover-
slipped. The sections were covered either with Entellan in 
toluene (Merck, Darmstadt, Germany) or, when pre-
treated with Sudan black B, with glycerol/gelatin (Sigma, 
Deisenhofen, Germany). 
Low-magnification mapping of BFB nuclei 
Mapping of cholinergic BFB nuclei was carried out on 
ChAT (Fig. 1) and Nissl-stained sections at 2.5 X primary 
magnification using a Leica LB100T microscope fitted 
with a high-resolution camera module (DC-100) that was 
attached to a Quantimet computerized image-analysis 
platform (Leica, Cambridge, United Kingdom). All sec-
tions were captured under identical illumination at 600 
dpi resolution. Sections were systematically sampled to 
allow complete overview of the BFB, and composite im-
ages were assembled using Paint Shop Pro (v. 7.01; Jasc 
Software Inc., Eden Prairie, MN). Nissl-stained sections 
were used to delineate particular BFB nuclei (data not 
shown) and were then fitted with images obtained after 
ChAT immunocytochemistry to yield the schematic fore-
brain maps presented in Figure 1. 
High-magnification microscopy 
High-power photomicrographs of ChAT-ir neuron popu-
lations were prepared using a Zeiss Axioplan microscope 
equipped with an AxioCam high-resolution camera (Zeiss) 
at 1,030 x 1,300 pixel resolution. Captured images were 
uniformly processed for contrast and brightness adjust-
ment using Paint Shop Pro (v. 7.01). Tissue samples 
double-labeled for ChAT and p75NTR, CB, CR, PV, TH, 
nNOS, or SP were first inspected using a Zeiss Axioplan 
fluorescence microscope equipped with appropriate single-
and double-bandpass filters (Nos. 15, 09, and 24). Images 
of selected specimens were then obtained using a Zeiss 
510 confocal laser scanning microscope. After color coding, 
ChAT immunolabeling always appears in red, whereas 
structures immunoreactive for the simultaneously stained 
marker are shown in green. Panels of images were gener-
ated by CorelDraw (v. 10.0; Corel Corp., Ottawa, Ontario, 
Canada). 
Quantitative image analysis 
Morphometric analysis of major cholinergic nuclei, such 
as the MS, VDB, HDB, NCa, nucleus putamen (Pu), olfac-
tory tubercule, accumbens nucleus, GP, VP, and MBN/SI 
complex was performed using a Leica Q-600HR comput-
erized image-analysis system. Complete series of sections 
stained for ChAT with nickel-enhanced 3,3'-
diaminobenzidine detection from three animals (two 
males and one female) were systematically sampled 
(35-40 sections/brain); brain regions of interest were 
manually delineated, and their surface area was deter-
mined (mm2). Subsequently, the number of neuronal 
perikarya with clearly discernible nuclei was counted in 
each brain region, whereas clearly fragmented nerve cell 
profiles were excluded from the sampling protocol (Har-
kany et al., 2001a, b). Because cholinergic BFB neurons 
are distributed in a largely inhomogeneous manner, pos-
ing a potential bias in disector-based cell counts (West, 
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1993), disector analyses were not carried out. It is worth 
noting that recent studies in our laboratory revealed no 
considerable difference in the number of cholinergic 
MBN/SI neurons when analyzed by either disector or ex-
haustive counting protocols (Horvath et al., 2002). To cor-
rect for the possibility of overestimation of cell numbers, a 
Floderus correction factor was introduced as described by 
Palkovits et al. (1971). Briefly, the average size of cholin-
ergic BFB nuclei was determined in all forebrain regions 
of interest, and a clearly discernible nucleus was consid-
ered as 8.9 |xm in diameter (a; mean value). Insofar as 
intact neurons contained nuclei with an average radius of 
5.7 |im (r), the Floderus correction factor was calculated as 
f = 0.8077 in 30-p.m-thick sections (Tj), given that f = 
Ti/fTi + sqrtir2 - (a/2)2)]. The probability of double cell 
counts, based on the 180-p.m cross-sectional distance, was 
considered negligible. Thereafter, the average surface 
area of each brain region as well as the average number of 
ChAT-immunoreactive (ir) nerve cells was computed. Fi-
nally, by taking the length of each brain region along the 
z-axis, expressed as the number of sections spanned x 30 
|j.m, into account, the volume of individual brain areas and 
the corresponding number of ChAT-ir neurons were esti-
mated (Horvath et al., 2000, 2002). Neuron density was 
calculated as the ratio of the number of neurons and the 
volume of the particular brain region and expressed as cell 
number per cubic millimeter. An identical quantification 
protocol was applied when assessing the frequency of CB/ 
ChAT and nNOS/ChAT «¡localization, except that cell 
counts were performed using an appropriate double-
bandpass filter (No. 24; Zeiss) for simultaneous detection 
of Cy2 and Cy3 signals. 
The density of ChAT-ir projection fibers was determined 
in the cingulate cortex and in layer V of the retrosplenial 
cortex, forelimb, and hindlimb representations of the so-
matosensory cortex and in the parietal and occipital cor-
tices (Fleischhauer at al., 1980; Zilles, 1985). Moreover, 
the density of ChAT-ir terminals in the dorsal hippocam-
pus-was also recorded, in which hippocampal subfields 
were defined according to Freund and Buzs&ki (1996). 
Image analysis was performed using a standard protocol 
on a Quantimet Q-550IV image-analysis system (Harkany 
et al., 2000, 2001a, b) in all sections employed for quanti-
fication of cell numbers. Briefly, after background subtrac-
tion and gray-scale threshold determination, the surface 
area of skeletonized ChAT-ir fibers ([the area covered by 
ChAT-positive cholinergic fibers]/[the total sampling 
• area], given as percentages) was computed in each section 
using a 470-nm emission filter. Data on the volume of 
cholinergic nuclei, total numbers and density of the nerve 
cells, percentage of «¡localization for CB/ChAT and nNOS/ 
ChAT, and area density of cortical cholinergic projections 
were expressed as mean ± SEM. 
Nomenclature 
Cholinergic nuclei were identified according to the brain 
maps of Winkler and Potter (1911) and Urban and Rich-
ard (1972). In cases in which the anatomical description of 
a particular brain structure was not available, it was 
identified based on the corresponding structure in rat 
brain (Paxinos and Watson, 1986). Our nomenclature con-
formed to that introduced by Mesulam et al. (1983a, b) for 
the rhesus monkey and rat, but with some modifications 
because of interspecies differences (Butcher and Semba, 
1989). Importantly, ChAT immunocytochemistiy alone 
during the quantification process did not allow unequivo-
cal delineation of the anatomical boundaries of VP, MBN, 
and SI, the latter made up of p75NTR-immunonegative 
cholinergic neurons, so we subdivided these territories as 
VP and the largely diffuse MBN/SI complex. Delineation 
of cortical areas adhered to mapping studies in the cere-
bral cortex of rabbit (Fleischhauer et al., 1980) and rat 
(Zilles, 1985). 
RESULTS 
General considerations 
Rostrally, the MS appears as a small, compact nucleus 
in the midline of the brain and is surrounded by the 
lateral septal nuclei (Fig. 1AA'>B,B'). After gradual ex-
pansion, the MS reaches its maximal extent approxi-
mately at the coronal plain of bregma (Urban and Richard, 
1972; Fig. 1B,B'), whereas the fornix, as its major output 
pathway innervating the hippocampus, appears more cau-
dally (Fig. 1C,C',D,D'). Whereas the dorsal and lateral 
boundaries of the MS are clearly discernible, a more dis-
persed group of cholinergic neurons, termed the VDB, 
neighbors the MS ventraUy (Fig. 1B,B'). Because of the 
close proximity of these nuclei, they can be designated as 
the MS/VDB complex. Similarly to the organization of the 
rat BFB, the HDB is located lateroventrally from the 
VDB. Along the longitudinal axis of rabbit brain, the HDB 
extends laterally (Fig. 1B,B',C,C'). Subsequent to the dis-
appearance of the compact group of cholinergic HDB neu-
rons, the MBN forms the most caudal part of cholinergic 
BFB projection neurons in rabbit forebrain (Fig. 1D-F'). 
Tract-tracing studies in the rat BFB revealed that three, 
namely, the anterior, intermediate, and posterior, MBN 
subdivisions can be distinguished (Luiten et al., 1987; 
Gaykema et al., 1990). In the present study, we used the 
nomenclature of Gaykema et al. (1990) and identified the 
anterior MBN as extending caudally to the disappearance 
of the anterior commissure (Fig. 1D,D'), the intermediate 
MBN subdivision adjacent to the ventromedial surface of 
the GP (Fig. 1E,E'), and the compact posterior MBN sub-
division (Fig. 1F,F'). A diffuse population of cholinergic 
neurons situated ventromedially from the intermediate 
MBN forms the SI. Because ChAT immunolabeling does 
not provide a clear demarcation between these nuclei, 
they were further assigned as the MBN/SI complex. 
The capsula interna served for anatomical separation 
between the NCa and the Pu, which contained large cho-
linergic interneurons (Fig. 1A'-F'). Interestingly, a well-
separated ventral subregion of the Pu, referred to as the 
ventral putamen (Fig. 1C,C'), could also be identified. In 
conjunction with the disappearance of the core and shell 
(AcSh) divisions of the nucleus accumbens, which are lo-
cated ventromedially from the NCa and are often assigned 
as parts of the ventral striatum, the medial segment of the 
Pu borders the GP. The GP extends in the caudal direction 
and is enveloped by cholinergic neurons of the MBN (Fig. 
1D,D',E,E'). 
BFB cholinergic neurons provide innervation to several 
grisea in the rabbit forebrain. Whereas the present study 
was focused on cortical and hippocampal cholinergic pro-
jections, dense ChAT-immunoreactive (-ir) innervation 
was also visualized in the olfactory tubercule (Fig. 
lAA'.B.B'), the anteroventral thalamic nucleus (Fig. 
1F,F'), and the cortical, central, and basolateral amygda-
loid nuclei (Fig. 1F,F'). 
Fig. 1. Dis t r ibut ion of cholinergic basal forebra in (BFB) nuclei in 
rabb i t forebra in . A - F r e p r e s e n t schemat ic m a p s of ma jo r B F B nuclei 
t h a t were p repared u s ing sect ions s ta ined for choline ace ty l t rans-
ferase ( A ' - F ' l . Detai ls of t h e imag ing procedure a n d pa r t i cu la r 
anter ior-poster ior coordina tes of t h e cap tured p lanes a re re fe r red to in 
the text . Nuclei were ident i f ied a n d t e rmed according to the nomen-
c la ture introduced by Wink le r a n d Pot te r (1911) and U r b a n and 
Richard ( 1972), in conjunct ion wi th pa r t i cu la r des igna t ions of Paxinos 
and Watson ( 1986) in r a t bra in . N u m b e r e d te r r i tor ies (2A-2J ) corre-
spond to the high-power images shown in F igure 2. 1, Cen t ra l amyg-
daloid nucleus , capsu la r subdivis ion; 2, cen t ra l amygdaloid nucleus , 
medial subdivision; 3V, th i rd ventr icle; AcA, comissura anter ior , an-
ter ior pa r t ; AcC, accumbens nuc leus , core; Acp, commissu ra an te r io r , 
poster ior par t ; AcSh, accumbens nucleus , shell, AVN, an te roven t r a l 
t ha lamic nucleus; BLA, baso la te ra l amygdaloid nucleus; BMA, baso-
medial amygdaloid nucleus; CA, centra l amygdaloid nucleus; CaN, 
cortical amygdaloid nucleus; Cc, corpus cal losum; Cctx, c ingula te 
cortex; Ce, capsula ex te rna ; CeL, centra l amygdaloid nucleus , l a te ra l 
subdivision; Ci, capsula in te rna ; CRa, capsula r ad i a t a ; dHipp, dorsal 
hippocampus; f, fornix; Fsl, fissura sagi t ta l i s la tera l i s ; GP, globus 
pallidus; HDB, horizontal diagonal band of Broca; IM, in te rca la ted 
amygdaloid nucleus; IPAC, in ters t i t ia l nuc leus of poster ior l imb of 
accumbens; LOT, la te ra l olfactory tract; LS, la te ra l s ep tum; Lv, lat-
e ra l ventricle; (a,i ,p)MBN, magnocel lular basal nuc leus (anter ior , in-
te rmedia te , and poster ior subdivisions); MeAD, media l amygdaloid 
nucleus, anterodorsa l division; MnPO, median preoptic nucleus; MS, 
medial sep tum; NCa, nuc leus cauda tus ; opt, optic t rac t ; Ot, olfactory 
tubercule; Otp, olfactory tubercule , poster ior par t ; Pir , p i r i form cor-
tex; Pu, pu t amen ; Rt, re t icu lar tha lamic nucleus; SFi , septof imbrial 
nucleus; SI, subs t an t i a innomina ta ; SoCtx, somatosensory cortex; 
VDB, vertical diagonal band of Broca; VP, ven t r a l pal l idum; VPu, 
pu tamen , vent ra l subdivision. Scale bars = 1.2 m m . 
Fig. 2. Dis t r ibut ion of choline ace ty l t rans fe rase (ChAT)-
immunoreac t ive neu rons in the r abb i t basal forebra in (A-H) and of 
cholinergic t e rmina l s in the somatosensory cortex (h indl imb area ; I) 
a n d dorsa l h ippocampus (J) . C lus t e r s of mul t ipolar cholinergic ne rve 
cells were demons t r a t ed in the media l sep tum (A) a n d vertical (B) and 
horizontal (C; HDB) d iagonal b a n d s of Broca. Note t h a t C depicts 
sp indle-shaped CliAT-ir neu rons in the poster ior subdivision of the 
HDB. Cholinergic n e u r o n s in t h e magnocel lu lar nucleus basal is 
(MBN; D) and subs t an t i a i n n o m i n a t a (SI; E) fo rmed a largely inter-
re la ted neurona l ne twork in which MBN neurons appea red larger 
t h a n S I neurons . It is wor th no t i ng t h a t MBN neu rons were inter-
mingled with densely s ta ined pas s ing cholinergic fiber bundles (D). 
ChAT-ir neurons were f requent ly found in cell br idges between the 
nucleus c a u d a t u s (NCa) and p u t a m e n (Pu, F). Moreover, mul t ipo la r 
cholinergic in t e rneurons of s imilar size and dens i ty were observed in 
NCa (G) as well as in Pu (H). A dense ChAT-ir fiber ne twork was 
visualized throughout the cerebral cortex and exhibi ted a clear lam-
ina r dis t r ibut ion pa t t e rn . T h e h ighes t densi ty of cholinergic fibers was 
seen in layer V of the cerebral cortex (I). Cholinergic t e rmina l s in the 
h ippocampus also showed str ict topographical d i s t r ibu t ion . J is a 
reconstruct ion of the dorsal h ippocampus , wi th t h e h ighes t ChAT-ir 
t e rmina l densi ty in the s t r a t u m sup rapy ramida l e (Sp) of t h e CA1 and 
CA3 subfields. Note the f requen t presence of ChAT-ir i n t e rneu rons 
(arrows). IML, inne r molecular layer of the d e n t a t e gyrus ; Ip, s t r a t u m 
inf rapyramida le ; OML, ou te r molecular layer of t h e den t a t e gyrus; 
Or, s t r a t u m oriens; Rad, s t r a t u m r a d i a t u m . Scale b a r in H = 150 p m 
for A - H ; bar in I = 50 pm; bar in J = 280 p m . 
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T A B L E 2. M o r p h o m e t r i c P a r a m e t e r s of C h o l i n e r g i c N u c l e i in R a b b i t B a s a l F o r e b r a i n a s Revea led by 
C h o l i n e A c e t y l t r a n s f e r a s e ( C h A T ) I m m u n o c y t o c h e m i s t r y 1 
B r a i n r e g i o n S u b d i v i s i o n V o l u m e ( m m 3 ) T o t a l cell n u m b e r Ce l l d e n s i t y 
Nuclcus caudatus Anterior 13.9 ± 0.6 3,447 ± 367 177 ± 21 
Intermediate 8.1 ± 0.2 1,018 ± 78 89 ± 8 
Posterior 5.6 ± 0.9 659 ± 116 84 ± 6 
Putamen Anterior 7.1 ± 0.9 2,264 ± 290 227 ± 15 
Intermediate 5.5 ± 0.1 1,964 ± 134 250 ± 15 
Posterior 8.9 ± 1.3 2,387 ± 168 196 ± 14 
Medial septum 4.7 I 0.4 6,426 ± 1351 963 ± 218 
Vertical diagonal band of Broca 1.3 ± 0.1 3,028 ± 209 1,717 ± 269 
Horizontal diagonal band of Broca 1.8 ± 0.1 5,420 ± 727 2,087 I 303 
Shell of nucleus accumbens 4.9 ± 0.9 2,387 ± 267 373 ± 56 
Ventral pallidum 1.8 ± 0.5 873 ± 225 331 ± 20 
Nucleus basalis magnocellularis Anterior 1.5 ± 0.1 2,006 ± 114 735 ± 98 
and substantia innominata Intermediate 2.14 ± 0 . 1 2.312 ± 249 994 ± 168 
Posterior 1.5 ± 0.3 2,806 ± 612 960 ± 81 
'Details of the sampling scheme, image-analysis protocol, and delineation of subdivisions of nucleus caudatus (NCa), putamen (Pu), and magnoccllular nucleus basalis 
(MBNVsubstantia innominata (SI) complex are described in Materials and Methods. Because ChAT immunocytochemistry alone did not allow unequivocal separation ofMBN from 
SI, these two nuclei were regarded as the MBN/SI complex. Total numbers of nerve cells refer to the amount of neurons in the entire volume of a part icular brain region, and 
neuronal density is reported as number of nerve cells per cubic millimeter. Data represent means ± SEM. 
Medial septum and vertical limb of the 
diagonal band of Broca 
Dense clusters of cholinergic neurons of the MS/VDB 
complex become already visible with low magnification 
(Fig. 1A',B'). Within the boundaries of the MS, ChAT-ir 
neurons are concentrated along the midline raphe of the 
septum and the outer edge of the nucleus and form mirror-
symmetrical, shell-like cell assemblies. The highest den-
sity of cholinergic cells can be found within some 100 p.m 
from midline (Figs. IB' , 2A). This laminar organization 
was less apparent in the VDB (Fig. 2B). Whereas the 
absolute number of ChAT-ir cells in the MS is approxi-
mately twofold higher than that in the VDB, the above-
mentioned nonhomogeneous distribution of ChAT-ir neu-
rons in the MS results in a lower mean density of nerve 
cells (Table 2). Cholinergic projection neurons in the MS 
and VDB were of intermediate size and appeared as bipo-
lar or multipolar nerve cells (Fig. 2A,B). Double-
immunofluorescence labeling for ChAT and p75N T R re-
vealed a virtually complete colocalization of the two 
cholinergic markers (Fig. 3A,A',B,B'). None of the addi-
tional markers was coexpressed in cholinergic perikarya 
(see, e.g., Fig. 4C,D,H). 
Horizontal limb of the 
diagonal band of Broca 
In general terms, the cytoarchitecture of the HDB re-
sembles that of the VDB, in which a dense cluster of 
multipolar ChAT-ir neurons is present (Fig. 1B',C'). High-
power microscopy in the posterior region of the HDB— 
corresponding to Figure 1C'—often revealed spindle-
shaped ChAT-ir perikarya (Fig. 2C). Quantitative 
analysis of cholinergic cell numbers in the HDB demon-
strated the highest density of ChAT-ir neurons among the 
cholinergic BFB nuclei investigated (Table 2). Similarly to 
the case in the MS and VDB, all ChAT-ir neurons exhib-
ited p75N T R immunoreactivity (data not shown), whereas 
none of the other markers showed colocalization with cho-
linergic HDB neurons (see, e.g., Fig. 4H). 
Pallidum 
The rostral expansion of the VP is emerging already at 
the level of the first appearance of the MS (Fig. 1A,A') and 
is often interrupted by striatal cell bridges between the 
olfactory tubercule and the AcSh. The neuropil is less 
densely stained for ChAT than the surrounding striatal 
regions (Fig. 1A'). In parallel with the disappearance of 
AcSh, the VP expands under the commissura anterior, 
whereas more caudally it seems to become identical with 
the SI. Cholinergic neurons situated in the VP region are 
similar in their morphological characteristics, density, 
and size to those of the AcSh (Table 2). Double-
immunofluorescence labeling, however, revealed that 
ChAT-ir neurons in the VP, but not in the AcSh, express 
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and, concomitantly with its caudal extension, becomes 
encircled by a ribbon-like cluster of cholinergic magnocel-
lular neurons that make up the MBN (Fig. 1D',E'). 
Magnocellular nucleus basalis/substantia 
innominata complex 
Concomitantly with the disappearance of the commis-
sura anterior, the anterior MBN subdivision can be dis-
tinguished, followed by the major—intermediate—part 
that transits into the compact posterior MBN subdivision. 
MBN neurons form clusters consisting of 5-20 ChAT-ir 
cells that are surrounded by densely stained fiber bundles 
(Fig. 2D). These cholinergic cell clusters exhibit a hetero-
geneous distribution pattern; e.g., some MBN-related neu-
rons are also visible in the internal lamina between the Pu 
and GP as well as in the capsula interna (Fig. 3C). 
Whereas subsets of ChAT-ir neurons of different sizes can 
be observed in this region, ChAT immunolabeling alone 
did not allow the unambiguous delineation of definite 
boundaries between the MBN and the SI, the latter being 
generally found ventromedially from the MBN in other 
mammalian species. Therefore, cell counts were per-
formed on the entire MBN/SI complex, where present, and 
on the posterior subdivision of the MBN (Fig. IF ' ) and 
revealed a gradual rostrocaudal increase in the total num-
bers of ChAT-ir neurons (Table 2). 
A dorsal-to-ventral descending gradient of p75NTR-ir 
neurons was present in the intermediate MBN/SI. Double-
immunofluorescence labeling for ChAT and p75N T R con-
firmed the presence of neurochemically distinct subpopu-
lations of cholinergic neurons (Fig. 3C,C'). Whereas 
virtually all large cholinergic nerve cells in the dorsolat-
eral MBN/SI complex were immunoreactive for p75NTR , a 
subpopulation of medium-sized cholinergic neurons (Fig. 
2E) was immunonegative for p75N T R in the ventromedial 
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Fig. 3. Coexpression of choline ace ty l t rans fe rase (ChAT; A-C) and 
low-affinity neurot rophin receptor p75 (p75N T R ; A ' - C ' ) in the medial 
sep tum (MS), vertical diagonal band of Broca (VDB), and magnocel-
lu lar nucleus basalis (MEN) as visualized by combined immunolabel-
ing us ing Cy2 (green)- and Cy3 (red)-tagged secondary antibodies, 
respectively. Note the over lap of t he two signals in the MS and VDB, 
the presence of cholinergic cells in t he capsula i n t e rna (Ci), and t he 
ring-like pa t t e rn of MBN neurons su r round ing the globus pal l idus 
(GP). p75N T R-negat ive cholinergic neurons were found on the puta-
men (Pu)/MBN border (arrows). Box in C indicates a high magnifica-
tion image of the terr i tory shown in F igure 4B. Scale bar in B' = 200 
p.m for A,B,A',B'; bar in C ' = 500 p.m for C,C' . 
subdivision (Fig. 4A). The difference in p75N T R immuno-
reactivity, thus, provides a firm basis for defining a border 
between the MBN and SI (Fig. 1D,D',E,E'). Interestingly, 
cholinergic neurons of the posterior MBN also contained 
CB (Fig. 4F) and nNOS (Fig. 41), whereas ChAT was not 
found in cells containing PV (Fig 4E) or CR (data not 
shown). 
Nucleus caudatus, putamen, 
and nucleus accumbens 
As shown in Figure 1, the capsula interna provides 
s t ructural separation between the NCa and Pu in the 
rabbit BFB. Although the capsula interna appears to be 
immunonegative for ChAT, it is often interrupted by 
str iatal cell bridges tha t provide connections between 
the NCa and the Pu (Fig. 2F). Both the NCa and the Pu 
contain significant numbers of cholinergic interneurons. 
However, the pat tern of neuronal density, as a function 
of the rostrocaudal axis, differs markedly (Table 2). 
Whereas a clearly descending anterior-to-posterior gra-
dient in the density of ChAT-ir neurons was demon-
strated in NCa, a more even distribution of cholinergic 
interneurons is characteristic for Pu. All cholinergic 
neurons of the NCa and Pu are large, round, and mul-
tipolar (Fig. 2G,H), resembling cholinergic s tr iatal in-
terneurons of other animal species (Sofroniew et al., 
1982; Geula et al., 1993), and those si tuated in s t r ia ta l 
cell bridges intruding into the capsula interna form a 
fusiform subset of ChAT-ir neurons (Fig. 2F). Whereas 
the NCa was devoid of any cellular p75N T R labeling, 
p75N T R-ir cells were found scattered in the ventrome-
dial and laterodorsal segments of Pu (Fig. 4B). None of 
the other neurochemical markers (calcium-binding pro-
teins, nNOS, TH, and SP) exhibited cellular colocaliza-
tion with striatal cholinergic perikarya. 
The accumbens complex could be divided into two sub-
divisions, by means of ChAT immunolabeling, namely, the 
lightly immunoreactive core and the densely stained AcSh 
nuclei. The core only exhibited diffuse ChAT-ir fiber stain-
ing. In contrast, AcSh not only consisted of a denser neu-
ropil staining for ChAT but also contained, though in a 
relatively low density, cholinergic nerve cells (Table 2). 
Based on their multipolar appearance and size similarity 
to cholinergic neurons in Pu, these ChAT-ir nerve cells 
could also be regarded as cholinergic interneurons (data 
not shown). 
Distribution of calcium-binding proteins, 
NOS, TH, and SP and their colocalization 
with cholinergic neurons 
Although our primary objective was to determine 
whether cholinergic neuron populations coexpress the 
calcium-binding proteins CB, CR or PV, attention was also 
paid to the general distribution pattern of calcium-binding 
protein-containing neurons in the rabbit BFB. Relatively 
few CB-ir cells were localized in the midline of MS and 
VDB, where they were surrounded by the cholinergic cell 
columns or intermingled with ChAT-positive perikarya 
(Fig. 4C). Interestingly, CB-ir cholinergic neurons were 
present in the posterior MBN (Fig. 4F) but not in the 
anterior or intermediate MBN subdivisions. Quantitative 
analysis demonstrated that 19.1% ± 0.4% of cholinergic 
neurons in the posterior MBN subdivision exhibited CB 
immunoreactivity. CR-positive neuronal perikarya were 
also present mainly in the proximity of the MS midline. In 
comparison with the distribution pattern of CB-ir neurons 
(Fig. 4C), however, a significantly broader zone of inter-
mingled CR-ir and ChAT-ir neurons was evident in the 
MS and VDB (Fig. 4D). The dorsal subdivision of the NCa 
and Pu exhibited intense CB and CR immunoreactivity, 
where both cellular and neuropil labeling for these 
calcium-binding proteins was present, and virtually all 
striatal principal neurons expressed CB. Although CR-
containing cells were scattered in the rabbit VP and 
MBN/SI complex, numerous CR-ir passing fibers, though 
with heterogeneous densities, were visualized. Surpris-
ingly, a relatively low intensity of PV-ir neuronal struc-
tures was observed in the MS and VDB relative to other 
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Fig. 4. Immunofluorescence label ing of choline acetyl t ransferase 
(ChAT; appears red a f t e r color coding) combined with selected neuro-
chemical m a r k e r s (color coded in green) in the rabb i t basal forebrain. 
A and B demons t ra te pa r t i a l colocalization of ChAT with the low-
affinity neurot rophin receptor (p75 N T R ) in subs t an t i a innominata (SI) 
and pu tamen (Pu). The calcium-binding proteins calbindin D-28k 
(CB), calret inin (CR), and p a r v a l b u m i n (PV) did not colocalize with 
ChAT in the medial s e p t u m (MS; C), vert ical diagonal band of Broca 
(VDB; D), and magnocel lular nuc leus basalis (MBN; E), respectively 
Interest ingly, however, a port ion of ChAT-immunoreact ive (ir) neu-
rons contained CB in t he poster ior subdivision of MBN (F). Low-
power photomicrograph of the pallidal region (VP) depicts s t rong 
TH-positive input in the vicinity of cholinergic neurons (G). Also, 
substance P-ir fibers sur round and te rmina te on cholinergic neurons 
of the horizontal diagonal band of Broca (HDB; H). Nitr ic oxide 
synthase (nNOS) was infrequent ly coexpressed in some cholinergic 
MBN neurons (I), but colocalization of n N O S wi th cholinergic 
per ikarya in o ther invest igated nuclei was not observed. Colocaliza-
tion of the par t icular marke r s appears in yellow/orange. Scale bars = 
100 p m in A,D, 50 | im in B,F,I, 200 p m in C,E, 250 p m in G, 20 p m 
i n H . 
BFB nuclei. In contrast, the NCa and Pu displayed a 
dense subset of PV-positive neurons that outnumbered 
the cholinergic neurons (data not shown). Similarly to the 
case in the MS, all three calcium-binding proteins were 
also present in the HDB and formed neuronal populations 
distinct from those of cholinergic nerve cells. Irrespective 
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of their particular calcium-binding protein content, non-
cholinergic neurons usually appeared to be smaller than 
cholinergic cells in rostral nuclei of the BFB. In fact, PV-ir 
neurons showed a wide range of somatic diameters, being 
largest in the GP, where they seemed to be as large as 
ChAT-ir neurons. Likewise, large PV-positive neurons 
were frequently observed in the VP and MBN/SI complex 
(Fig. 4E). 
TH-ir projection fibers were localized in cholinergic ar-
eas that receive innervation from dopaminergic midbrain 
nuclei (Fig. 4G). These TH-positive fibers were of veiy thin 
appearance. Prominent TH immunosignal was present 
throughout the NCa and Pu as well as the AcSh. The 
distribution of TH-positive fiber projections was found as a 
distinctive marker between the AcSh and the VP, inas-
much as the VP exhibited significantly lower TH immu-
noreactivity, which became evident only in passing fibers 
(Fig. 4G). A few passing fibers were also visible in other 
cholinergic nuclei, such as MS, VDB, and MBN/SI complex 
(data not shown). 
In parallel with TH-ir fibers, SP-containing projections 
were also found in the rabbit BFB that might originate in 
midbrain nuclei (Csillik et al., 1998). Similarly to the case 
in the rat (Bolam et al., 1986), SP-ir fibers were found 
predominantly in pallidal territories, whereas a lower 
density of SP-ir input was demonstrated in the NCa and 
Pu. However, other cholinergic nuclei, including the MS, 
HDB, and MBN, also received SPergic innervation. Inter-
estingly, the MS was relatively weakly labeled for SP, 
whereas the lateral septum exhibited strong SP immuno-
reactivity. Similarly, cholinergic neurons in the HDB were 
embedded in a dense network of SP-ir fibers that seemed 
to form synaptic terminals on ChAT-ir neurons (Fig. 4H). 
In contrast to our data on TH immunoreactivity in the 
AcSh and VP, SP-positive fibers were abundantly present 
in VP, but not in AcSh, making these two markers ideal 
for the demarcation of these nuclei (data not shown). 
nNOS-ir neurons were found only in striatal (NCa, Pu 
and AcSh) and pallidal (VP) subregions, where nNOS 
labels a group of noncholinergic small to medium-sized 
neurons. Other BFB nuclei were mostly devoid of nNOS 
immunoreactivity. Interestingly, a few cells coexpressing 
ChAT and nNOS were observed in the posterior MBN 
subterritory (Fig. 41), with a frequency of <1%. 
Cholinergic terminals in the 
neocortex and hippocampus 
Similarly to the case in other animal species, the rabbit 
cerebral cortex displayed a clear laminar distribution of 
cholinergic projection fibers. ChAT-ir fibers formed a 
dense network of fine axons (Fig. 21) with apparently 
highest densities in layers I and V of the cerebral cortical 
areas investigated. Morphometric analysis was performed 
on layer V of the cerebral cortex because of its clear, 
distinctive borders with adjacent cortical laminae and 
demonstrated a largely homogeneous distribution of cho-
linergic terminals irrespective of the particular cortical 
subfield investigated (Table 3). Interestingly, the adult 
rabbit neocortex contained only a few, faintly immunore-
active cholinergic interneurons, primarily in the somato-
sensory and retrosplenial areas. 
Similarly, a strictly organized cholinergic fiber pattern 
was apparent in the dorsal hippocampus. Determination 
of the surface area density of cholinergic axons revealed 
the highest density of ChAT-ir innervation in the supra-
TABLE 3. Density of Choline Acetyltransferase (ChAT)-Immunoreactive 
Terminals in Cerebral Cortex and Hippocampus1 
Brain region Subdivision Fiber density 
Cortez Cingulatc 10.2 £ 2.6 
Retrosplenial 9.5 £ 2.2 
Somatosensory (FL) 12.0 £ 1.3 
Somatosensory (HL) 8.2 £ 1.3 
Occipital 8.1 £ 0.6 
Perietal 9.2 £ 1.9 
Hippocampus CAI suprapyrvmidale 18.3 £ 1.6 
CAI infrapyrsmidalc 12.9 £ 1.2 
CA1 oriens 6.8 £ 0.9 
CAI radiatum 4.6 £ 0.6 
CAS auprapyramidalc 16.8 £ 2.1 
CAS infrapyramidele 10.6 £ 1.3 
CAS oriens 6.4 £ 1.2 
CAS radiatum 4.8 £ 0.6 
DG1ML 11.6 £ 1.7 
DG OML 10.8 £ 2.8 
distribution of ChAT-immunorcactivc projections, originating in cholinergic basal 
forcbrain nuclei, was determined in layer V of the rabbit neocortex and dorsal hip-
pocampus. Divisions of ccrebra] cortical areas wore identified and termed as introduced 
by ZiUos (1985), whereas those of the dorsal hippocampus correspond to the description 
of Freund and Buielki (1996). Fiber density is presented as the mean surface area 
covered by skeletonized ChAT-ir projections. Data are expressed aa means — SEM. FL, 
forelimb representation; HL, hindlimb representation; DG IML, inner molecular layer 
of the dentate gyrus; DG OML, outer molecular loyer of the dentate gyrus. 
pyramidal layer of both the CA1 and the CA3 subfields 
(Fig. 2J). It is worth noting that homogeneous distribution 
of ChAT-ir fibers was found in the inner and outer molec-
ular layers of the dentate gyrus (Table 3). Multipolar 
ChAT-ir nerve cells were frequently observed in the dorsal 
hippocampus (Fig. 2J). 
DISCUSSION 
Our report demonstrates that, as in other classes of 
mammals, including rodents and primates, cholinergic 
neurons form a confluent series of nuclei in the BFB of the 
rabbit, in which two classes of ChAT-ir nerve cells were 
identified: projection neurons of MS, VDB, HDB, and 
MBN/SI and interneurons of NCa, Pu, VP, whereas the 
GP was devoid of cholinergic cells. Projection neurons of 
the rabbit BFB provided dense, topologically organized 
innervation to the cerebral cortex and hippocampus. In-
terestingly, cholinergic interneurons were frequently seen 
in the hippocampus but were scarce in neocortical areas. 
Analysis of the neurochemical heterogeneity of cholinergic 
cell populations in rabbit BFB revealed the sparse occur-
rence of CB (-19%) and nNOS (<1%) in cholinergic neu-
rons of posterior MBN, a finding that provides a phyloge-
netic niche for the rabbit forebrain cholinergic system 
between rodents (with partial nNOS coexpression; 
Schober et al., 1989; Brauer et al., 1991; Geula et al., 1993) 
and primates (with partial CB coexpression; Chang and 
Kuo, 1991; Côté and Parent, 1992; Geula et al., 1993; 
Ichitani et al., 1993; Hârtig et al., 2002). This assumption 
is further supported by recent phylogenetic concepts indi-
cating that the rabbit, a member of the mammalian order 
Lagomorpha, has a distant relationship to members of the 
orders of both Rodentia and Primates (Benton, 2000). 
Distribution of ChAT-ir neurons 
The distribution of ChAT-ir BFB projection neurons 
adheres well to the nomenclature introduced by Mesulam 
et al. (1983a, b). In particular, the rabbit MS may corre-
spond to the "Chi" subdivision, the VDB may be regarded 
as the "Ch2" cell group, and the HDB and the MBN/SI 
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complex can be assigned as the "Ch3" and "Ch4" regions, 
respectively. However, the mammalian species investi-
gated so far exhibit marked differences in the complexity 
of BFB nuclei (Butcher and Semba, 1989). Increasing com-
plexity of the BFB system, in parallel with cortical evolu-
tion, might be exemplified by the MBN. In the rat, the 
MBN can arbitrarily be divided into anterior, intermedi-
ate, and posterior subterritories, as was revealed by tract 
tracing studies (Luiten et al., 1987; Gaykema et al., 1990) 
that demonstrated distinct cortical projection patterns of 
ChAT-ir cholinergic MBN neurons. In contrast, the com-
plexity of MBN gradually increases in primates and hu-
mans and can be subdivided into five and six subsectors, 
respectively (Mesulam and Geula, 1988). Here, we defined 
three—anterior, intermediate, and posterior—MBN sub-
sectors based on the lack and/or presence of adjacent cho-
linergic nuclei and found these to be similar to those of 
rodents. Importantly, however, extensions of the MBN 
could also be observed in the lamina between the GP and 
the Pu, and ChAT-ir neurons coexpressing p75NTR in the 
capsula interna and adjacent to the basis of NCa could 
also be assumed to be parts of this nucleus (Maclean at al., 
1997). 
Stereology-based image analysis was used to determine 
the numbers of ChAT-ir nerve cells in BFB nuclei. In 
general terms, the total number of cholinergic neurons in 
rabbit BFB was approximately 37,000, -22,000 being cho-
linergic projection neurons in "Chl"-"Ch4" nuclei. To 
date, only a few studies have estimated the numbers of 
cholinergic neurons in BFB nuclei. In consideration of the 
findings of Smith et al. (1993, 1995) and Leanza (1998) 
and of Wu et al. (2000), who showed 1,000-2,000 cholin-
ergic neurons in the rat HDB/MBN vs. approximately 
55,000 ChAT-ir cells in the BFB of common marmoset, 
respectively, our data lend further support to the hypoth-
esis that the complexity of the BFB cholinergic system can 
be regarded as a phylogenetic correlate of the differentia-
tion of the cerebral cortex. In addition, the rabbit HDB 
consists of approximately the same amount of ChAT-ir 
cells as the MS, which is a hallmark of macrosmatic ro-
dents (Brashear et al., 1986) and carnivores (Gritti et al., 
1998), whereas the relative number of HDB cholinergic 
cells is much lower in the microsmatic primates (Mesulam 
et al., 1984). In contrast, the dorsal striatum (NCa and Pu) 
closely resembles that of primates, inasmuch as the cap-
sula interna provides a clear structural separation be-
tween the two nuclei. Taken together with these data, our 
morphological analysis supports the theozy of an in-
creased complexity of cholinergic BFB nuclei in the rabbit 
compared with those of rodents (Leanza, 1998; Smith and 
Booze, 1995). It is likely that Old Word primates, such as 
apes and humans, with a large brain size, may bear even 
many more ChAT-ir neurons. As strict quantitative anal-
ysis of cholinergic BFB cells is as yet lacking, so accurate 
interspecies comparisons of absolute or relative numbers 
of the BFB cholinergic neurons cannot be made. 
The density and distribution of cholinergic neurons in 
the BFB are not uniform, which is due predominantly to 
the alternating density of intermingled noncholinergic— 
primarily y-aminobutyric acidergic—cells (Freund, 1989). 
For example, cholinergic neurons in the MS and VDB are 
situated in the midline and in compact lateral cell columns 
that are intermingled with noncholinergic cell popula-
tions, providing an onionskin-like structure to the nucleus 
(Kiss et al., 1990; Brauer et al., 1991; Jakab and Leranth, 
1995). Similarly, the parallel existence of cholinergic and 
noncholinergic neuron populations could also be observed 
in the HDB and MBN/SI complex, but with considerable 
differences in the relative densities of cholinergic and 
noncholinergic nerve cells (Sarter and Bruno, 2002). 
Distribution of p75NTR-ir neurons 
In the present study, a high density of p75NTR-ir neu-
rons was demonstrated throughout the "Chln-''Ch4" re-
gions of the rabbit BFB. Double-immunofluorescence la-
beling experiments showed abundant (»localization of 
ChAT and p75NTR in these nuclei. Whereas virtually all 
cholinergic neurons expressed both markers in the MS, 
VDB, and HDB regions, a subpopuJation of cholinergic 
cells located in SI was devoid ofp75 R immunoreactivity. 
We assume that these neurons correspond to p75NT -
negative cholinergic neurons in the rat that are known to 
project to the amygdala (Heckers et al., 1994). It is worth 
noting that, in contrast to the case in the rat, the VP 
contains a few large cholinergic projection neurons that 
coexpress p75NTR (see also Riedel et al., 2002). Impor-
tantly, p75NTR-ir cells without ChAT (»expression were 
not detectable in the rabbit BFB. 
Detailed assessment of the distribution of p75NTR-ir 
neurons in the BFB of the rabbit also revealed some dif-
ferences from other mammalian species. For example, a 
unique ribbon-like distribution of large cholinergic neu-
rons can be observed around the GP, often extending into 
the capsula interna. Similar, though not identical, local-
ization of cholinergic neurons is known in mouse (Rofiner 
et al., 2000), rat (Riopelle et al., 1987; Springer et al., 
1987; Kiss et al., 1988), nonhuman primates (Riopelle et 
al., 1987; Wu et al., 2000), carnivores (Tremere et al., 
1998, 2000), artiodactyles (Tremere et al., 2000), marsu-
pials (our unpublished observations), and humans (Hefti 
et al., 1986; Mufson et al., 1989). We classified these cells 
as MBN-related projection neurons based on their spatial 
relationships to other cholinergic neurons. p75NTR-positive 
cholinergic intemeurons were found only in the Pu and not 
in the NCa, as was also described for sheep (Ferreira et al., 
2001) and rat (Kokaia et al., 1998), whereas widespread 
distribution of p75NTR-ir cells in the NCa, Pu, and nucleus 
accumbens was seen in the common marmoset (Maclean et 
al., 1997). 
Neurochemical heterogeneity of 
cholinergic neurons 
From a neurochemical point of view, cholinergic neu-
rons of the rabbit BFB form a relatively homogeneous cell 
population. Although some cholinergic neurons coex-
pressed CB or nNOS in the posterior part of the MBN, 
(»localization of ChAT and any of the other neurochemical 
markers investigated was not demonstrated. 
In the rat, distinct subpopulations of cholinergic projec-
tion neurons are immunoreactive for nNOS (Schober et 
al., 1989; Brauer et al., 1991; Geula et al., 1993). In con-
trast, nNOS is entirely absent in cholinergic projection 
cells of primates (Geula et al., 1993; Wu et al., 2000), 
where ChAT- and nNOS-positive neurons form nonover-
lapping populations throughout the "Chl"-"Ch4" regions. 
nNOS immunoreactivity is absent in cholinergic neurons 
of the rabbit "Chl"-"Ch3" cell groups, although some 
nNOS-containing cholinergic neurons are present in the 
posterior MBN subdivision. It is noteworthy that this 
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nNOS immunoreactivity is apparently weaker than that 
of cortical neurons. 
In the rabbit, CB expression was confined to cholinergic 
MBN neurons, whereas all other cholinergic cells were 
devoid of CB immunoreactivity. Comparative studies 
demonstrated that CB immunoreactivity is absent in cho-
linergic neurons of the rat BFB; conversely, almost all 
ChAT-ir neurons contain CB in the primate forebrain 
(Chang and Kuo 1991; Chang et al., 1991; Geula et al., 
1993; Ichitani et al., 1993; Härtig et al., 2002). Moreover, 
Ichimiya et al. (1989) reported that CB-containing cholin-
ergic projection neurons are first affected in Alzheimer's 
disease and are more severely damaged than cortical 
CB-ir nerve cells (Ferrer et al., 1993; Wu et al., 1997). 
All BFB areas known to receive dopaminergic innerva-
tion contained strong TH-ir fiber labeling. No cell popula-
tion with TH immunoreactivity was visible within the 
rabbit BFB. Although this finding corresponds to findings 
for nearly all other investigated species, TH immunoreac-
tivity was reported in "Ch4" cholinergic cells in the com-
mon marmoset (Wisniowski et al., 1992; Wu et al., 2000). 
Distribution of cholinergic terminals in the 
cerebral cortex and hippocampus 
Similarly to the case in other mammalian species, cor-
ticopetal and septohippocampal cholinergic projections 
appear as a fine fiber network in target areas. ChAT-ir 
projections were present in all layers of the neocortical 
territories and hippocampal subfields investigated. In the 
cerebral cortex, the highest density of cholinergic projec-
tions was observed in layer V, followed by layers I—II = 
IV-VI > III. Quantitative analysis of the area density of 
ChAT-ir cholinergic projections in layer V, which provides 
information on the percentage area covered by skeleton-
ized cholinergic fibers in a particular sampling field, dem-
onstrated a relatively even distribution of cortical cholin-
ergic projections, with peak density values in the FL and 
cingulate cortices. Interestingly, layer V of the FL and 
cingulate areas received the most dense cholinergic inner-
vation also in the rat (unpublished observations), which 
may point to at least partial similarities in the cortical 
innervation of these species. Likewise, the hippocampal 
innervation of the rabbit also resembled that of the rat 
(Freund and Buzsäki, 1986), inasmuch as the CA1 and 
CA3 strata suprapyramidale and infrapyramidale and the 
inner moleculare layers and outer moleculare layers of the 
dentate gyrus are most abundantly covered by cholinergic 
fibers. Although tract tracing and electron microscopy 
were not performed, it seems likely that cholinergic fibers 
terminate on both principal and interneuron populations 
in the hippocampus. 
From a methodological point of view, our quantitative 
analysis using surface area density measurements was 
aimed at demonstrating potential differences in the inner-
vation density of particular projection areas, because this 
approach was efficiently used to record lesion-induced 
changes in cortical and hippocampal cholinergic innerva-
tion (Harkany et al., 2000,2001a, b; Honrath et al., 2002). 
In contrast, our data, in terms of the absolute values, can 
be considered only as fine approximations yielded by using 
standard light and threshold adjustments throughout the 
quantification procedure. 
CONCLUSIONS 
The present studies provide neuroanatomical evidence 
of the distribution of cholinergic neurons in major BFB 
nuclei and their neocortical and hippocampal projections 
in the rabbit brain. Here we demonstrate that BFB nuclei 
containing cholinergic projection neurons can be subdi-
vided into the MS, VDB, HDB, and MBN/SI complex, and 
their boundaries appear largely identical to those of cor-
responding structures in the rat. Cholinergic projection 
fibers formed a topologically organized network in the 
neocortex and hippocampus and exhibited a clear laminar 
distribution pattern. Overall, our data, yielded by ChAT 
and p75NTR immunocytochemistry, showed that major 
morphological characteristics of cholinergic corticopetal 
and septohippocampal magnocellular projection systems 
in the rabbit BFB resemble those of rodents, such as the 
rat and mouse. In contrast, analysis of the number and 
density of cholinergic neurons in BFB nuclei revealed 
more cholinergic neurons in the rabbit than were previ-
ously described for rodents. Moreover, double-immuno-
fluorescence labeling of ChAT and selected neuronal 
markers revealed some neurochemical peculiarities, such 
as the limited presence of CB and nNOS in cholinergic 
neurons of the posterior MBN. These latter characteris-
tics, however, can be considered as signs of the evolution-
ary separation of the rabbit from other mammalian 
species. The neurochemical heterogeneity of MBN subdi-
visions may markedly influence the sensitivity and recov-
ery potential of cholinergic MBN neurons after noxious 
stimulation, which should be considered in future phar-
macological models of cholinergic dysfunction in this ani-
mal species (if possible). 
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Cholinergic basal forebrain neurons (CBFN) expressing the low-af-
finity neurotrophin receptor p75 (p75NTR) were previously selec-
tively labeled in vivo with carbocyanine 3 (Cy3)-tagged anti-
p75NTR, but the applied l92lgG-conjugates recognized p75NTR only 
in rat.The antibody ME 20.4 raised against human p75 R had been 
shown to cross-react with the receptor in monkey, raccoon, sheep, 
cat, dog, pig and rabbit. Hence, for in vivo labeling of rabbit C B F N in 
the present study, ME 20.4 was fluorochromated with Cy3-N-hy-
droxysuccinimide ester and purified Cy3-ME 20.4 was injected 
intracerebroventricularly. Two days post-injection, clusters of 
Cy3-ME 20.4 were found in C B F N displaying choline acetyltrans-
ferase-immunoreactivity. Following photoconversion, electron 
microscopy revealed fluorochromated antibodies in secondary 
lysosomes. In conclusion, Cy3-ME 20.4 might become an appropri-
ate marker for CBFN in live and fixed tissues of various mammalian 
species. NeuroReport 13:1395-1398 © 2002 Lippincott Williams & 
Wilkins. 
Key words: Choline acetyltransferase; Cholinergic system; Low-affinity neurotrophin receptor; Oxygen-enriched photoconversion 
INTRODUCTION 
Severe damage to cholinergic neurons of the basal forebrain 
(BFB) is a major neuropathological hallmark of Alzheimer's 
disease, and this has prompted investigations focused on 
this brain region in various mammalian species [1], 
Neuroanatomical studies have achieved the identification 
of cholinergic nerve cells by the detection of their marker 
enzyme choline acetyltransferase (ChAT, EC 3.2.1.6) as well 
as of vesicular acetylcholine transporters. An additional 
selective marker of cholinergic BFB neurons is the low-
affinity neurotrophin receptor p75 (p75NTR), as was demon-
strated in the rat [2], raccoon [3], monkey [4] and human [5], 
Targeting of p75N,TR led to the development of cholinergic 
immunolesion models. In particular, the • 2 a a application 
of antibodies directed against an extracellular epitope of rat 
p75NTR and conjugated to the ribosome-inactivating toxin 
saporin (192IgG-saporin) caused selective lesions of choli-
nergic projection neurons in the rat BFB [6], 
A further derivative of 192IgG, namely its conjugate with 
the red fluorochrome carbocyanine 3 (Cy3-192IgG), was 
introduced as a tool for the selective labeling of rat 
cholinergic, p75NTR-bearing neurons both • 2 a- a £7,8] and 
.2 a. 192IgG-conjugates are commonly infused 
intracerebroventricularly and bind to p75NTR on cholinergic 
terminals, become internalized as ligand/receptor com-
plexes and are transported retrogradely to the perikarya of 
cholinergic BFB neurons [6], Internalized Cy3-192IgG 
molecules form clusters in secondary lysosomes [8], 
Whereas ribosome inactivation by saporin causes neuronal 
death [6,10], Wu t o[ll] demonstrated that pre-labeling of 
cholinergic neurons with Cy3-192IgG does not alter their 
electrophysiological and pharmacological properties in »" 
a • a jprain slice preparations containing the medial septum/ 
diagonal band complex (MSDB). Concordantly, identifica-
tion of cholinergic nerve cells with Cy3-192IgG in brain 
slices led to new insights in the synaptic organization of 
neurons in the MSDB with implications for learning and 
memory [11,12], 
However, 192IgG conjugates recognize p75NTR only in the 
rat precluding their application in other mammalian species 
(e.g. monkeys) with a BFB chemoarchitecture resembling 
that in humans [13], In contrast, the monoclonal antibody 
ME 20.4 raised against an extracellular epitope of the human 
p75NTR [14] was demonstrated to cross-react with p75NTR 
also in monkey, raccoon [3], rabbit, pig, dog and cat [15], 
Accordingly, the ME 20.4-saporin conjugate was shown to 
be a selective cholinotoxin in the common marmoset [16], 
rhesus monkey [17], rabbit [18] and sheep [19], 
To overcome the restriction of • 2 a • a labeling in the rat, 
the present study investigated whether Cy3-ME 20.4 can be 
employed as a marker of living cholinergic neurons in a 
wide range of mammalian species expressing analogues of 
the human p75NTR. Encouraged by recent data on ME 20.4-
saporin-induced immunolesions of cholinergic cells and 
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subsequent P-amyloid deposition in the rabbit brain [18], the 
potential of Cy3-ME 20.4 as a label for cholinergic nerve 
cells was exemplified in studies on BFB neurons of this 
animal species. 
MATERIALS AND METHODS 
Preparation of Cy3-ME 20.4: Cy3-ME 20.4 was prepared 
by coupling the antibody with a chemically activated ester 
of Cy3 under reaction conditions proved to maintain the 
antigen-binding properties of ME 20.4 [20]. Four hundred 
micrograms of ME 20.4 (pure IgG; AB-N07, Advanced 
Targeting Systems, San Diego, CA, USA) were reacted with 
a monofunctional Cy3-Ô-hydroxysuccinimide ester (Anti-
body Cy3 Labeling Kit, Amersham Pharmacia Biotech, 
Freiburg, Germany) according to the instruction of the 
manufacturer at pH 9.3 for 1 h, but with doubled dye:pro-
tein ratio. Thereafter, the reaction mixture was dialyzed 
against phosphate-buffered saline (3 x 4h) and the con-
centration of Cy3-ME 20.4 was adjusted to approximately 
0.5mg/ml prior its use for intracerebroventricular (i.e.v.) 
injections. 
Surgical procedure: New Zealand white rabbits of either 
sex (2 = 5; 2.3-5.1 kg; 4-21 months of age) were used in this 
study. The rabbits were anesthetized with a mixture of 
ketamine (50mg/kg; Exalgon, Merck, Hallbergmoos, Ger-
many) and xylazine (4mg/kg; Rompun, Bayer AG, Lever-
kusen, Germany), and their heads were mounted in a 
stereotaxic frame. Two animals received unilateral i.c.v. 
injections, and three animals were injected bilaterally with 
16 ill Cy3-ME 20.4 at an infusion speed of 0.5pl/min with a 
Hamilton microsyringe (Hamilton, Bonaduz, Switzerland). 
Injection co-ordinates were applied according to Beach »"{,<> 
[18] at AP = 0.0 mm, L = 2.2mm and DV = 9.0/7.5 mm 
relative to bregma. All efforts were made to minimize 
animal suffering throughout the experiments including 
administration of the analgetic Metamizol (150mg/kg; 
Berlosin, Berlin-Chemie, Germany) immediately after op-
eration. The antibiotic Enrofloxacin (10 mg/kg daily; Baytril, 
Bayer AG) was given orally throughout the post-injection 
period. The care and treatment of the animals were in 
accordance with the European Communities Council Direc-
tive (86/609/EEC) and approved by the Laboratory Animal 
Care and Use Committee of the University of Leipzig (TVV-
Nr.15/00). 
Immunocytochemistry and electron microscopy: Two days 
post-injection rabbits were transcardially perfused with 4% 
paraformaldehyde containing either 0.5% glutardialdehyde 
(three animals) or 0.1% glutardialdehyde (two animals) in 
0.1 M phosphate-buffer (pH 7.4). Whole brains were 
removed from the skulls, divided into fore- and hindbrain 
regions and post-fixed overnight in 4% paraformaldehyde. 
Two forebrains were coronally sectioned on a vibratome at 
50 pm and the remaining tissue was cryoprotected and cut 
at 30 pm on a cryostat microtome. Sections spanning the 
MSDB and the anterior subdivision of the nucleus basalis 
magnocellularis were washed with Tris-buffered saline 
(TBS, 0.1 M, pH 7.4), rinsed in distilled water, mounted, 
air-dried and coverslipped with Entellan (in toluene; Merck, 
Darmstadt, Germany). 
To determine the specificity of • 2 'labeling, Cy3-ME 
20.4 pre-labeled sections were applied to the concomitant 
immunolabeling of ChAT and the calcium-binding protein 
calretinin. Non-specific binding sites for the immunorea-
gents were primarily blocked with 5% normal donkey 
serum in 0.1 M Tris-buffered saline (TBS) containing 0.3% 
Triton X-100 for l h . Subsequently, the sections were 
incubated with a mixture of affinity-purified goat anti-
ChAT (1:25; AB144P, Chemicon International; Hofheim, 
Germany) and rabbit anti-calretinin (1:300; AB149, Chemi-
con) diluted in the blocking solution for 16 h. Next, 
rinsed sections were reacted with a cocktail of Cy2-tagged 
donkey anti-goat IgG and Cy5-conjugated donkey anti-
rabbit IgG (20 ng/ml; Dianova, Hamburg, Germany) diluted 
in TBS containing 2% bovine serum albumin for 1 h. 
Omission of the primary antibodies in control experiments 
led to the absence of any cellular Cy2- and Cy5-labeling. 
After the cytochemical procedures the sections were rinsed, 
mounted, air-dried and coverslipped in Entellan. Fluores-
cence microscopy was performed using an Axioplan 
microscope (Zeiss, Oberkochen, Germany) and selected 
sections were inspected with a Zeiss 510 confocal laser-
scanning microscope. 
To quench the autofluorescence caused by lipophilic 
Iipofuscin-like compounds in sections from 21-month-old 
rabbits, tissue was treated with Sudan Black B according to 
Schnell »"•¿'6 [21] but prior to the immunofluorescence 
labeling of cholinergic neurons. All Sudan Black B-pre-
treated sections were embedded in glycerol/gelatin (Sigma, 
Deisenhofen, Germany). 
The subcellular distribution of Cy3-ME 20.4 was deter-
mined following photoconversion of Cy3-ME 20.4 into an 
electron-dense reaction product applying oxygen-enriched 
photoconversion in a closed conversion chamber as de-
scribed previously [8]: Specimens were analyzed with a 
Zeiss 900 electron microscope. 
RESULTS 
Two days following the i.c.v. infusion of Cy3-ME 20.4 there 
was strong punctate labeling in many cells of the MSDB 
(Fig. 1) that became less intense in the nucleus basalis 
magnocellularis. This staining pattern was observed irre-
spective of the concentration of glutardialdehyde in the 
fixative. In comparison to rabbits unilaterally infused with 
Cy2-ME 20.4, bilaterally injected animals appeared to 
contain more • 2 *• Mbbeled nerve cells in both hemi-
spheres. 
X •• ' labeling of Cy3-ME 20.4 was exclusively found in 
cholinergic neurons, as revealed by their immunoreactivity 
for ChAT (Fig. la) and p75NTR (not shown). In contrast, 
.2 i. «J^beling was never observed in non-cholinergic, 
calretinin-immunoreactive nerve cells (Fig. lb) that are 
known to be intermingled with cholinergic neurons in the 
border zone of the medial and lateral septum [22] and in 
magnocellular, parvalbumin-containing GABAergic BFB 
neurons (not shown). 
It is noteworthy that treatment of the sections from 21-
month-old rabbits with Sudan Black B quenched the 
autofluorescence caused by lipophilic lipofuscin-like com-
pounds. Importantly, Sudan Black B treatment only slightly 
diminished the intensity of • 2 *• * labeling with hydrophilic 
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Fig. I. The confocal laser-scanning micrograph (a) shows red punctate Cy3-ME 20.4 in vivo labeling in cholinergic neurons of the rabbit medial septum. 
Selectivity of Cy3 -ME 20.4 for cholinergic neurons was demonstrated by co-localization with choline acetyltransferase (ChAT) that appears green (Cy2). 
(b) Merged carbocyanine triple fluorescence staining of Cy3-ME 20.4 (red clusters) and immuaoreactivities for ChAT (Cy2, green) and calretinin (CyS. 
color-coded in blue) in the border zone between the medial and lateral septum confirmed the specificity of in vivo labeling for cholinergic neurons and its 
absence in non-cholinergic, calretinin-containing nerve cells. Bar = 25 pm. 
Fig. 2. Electron micrographs of cholinergic neurons in the medial septum (a) and. at higher magnification, in the diagonal band of Broca (b) following 
photoconversion of internalized Cy3 -ME 20.4.The in vivo label was predominantly present in secondary lysosomes (arrows) after two days of survival. In 
comparison to the photoconverted material, non-labeled primary lysosomes (arrowheads) are different in their size, shape and electron density. Prior to 
print, the brightness and contrast of the electron micrographie images were digitally adjusted and shading correction was performed to reduce the 
effects of uneven illumination. Bar = 500 nm (a). 250 nm (b). 
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Cy3 and of the subsequently performed Cy2-immunostain-
ing of cholinergic neurons. 
Electron microscopic analysis elucidated that Cy3-ME 
20.4 was predominantly located intracellularly in secondary 
lysosomes (Fig. 2a,b). 
DISCUSSION 
The granular cellular labeling of neurons in the rabbit BFB 
with i.c.v. applied Cy3-ME 20.4 resembled that of Cy3-192IgG 
in the rat BFB [7]. A subpopulation of cholinergic neurons in 
the MSDB was unlabeled by Cy3-ME 20.4 that also parallels 
the incomplete Cy3-192IgG labeling in the rat [7,11]. Recently, 
the counting of Cy3-192IgG-positive cells in the rat BFB 
revealed a medial septum > horizontal limb of the diagonal 
band > > nucleus basalis magnocellularis gradient of labeling 
efficacy [23]. An apparently similar gradient was observed 
after the • 2 a- "labeling with Cy3-ME 20.4; that, however, 
remains to be quantified. Future studies should also elucidate 
whether the • 2 "labeling with Cy3-ME 20.4 is long-term 
stable or undergoes gradual clearance from the neurons, as 
was previously shown for Cy3-192IgG in the rat [8]. 
The predominant location of Cy3-ME 20.4 in secondary 
lysosomes, as revealed by electron microscopy, is identical 
to the ultrastructural localization of Cy3-192IgG in rat basal 
forebrain neurons [8]. This finding also corresponds with 
the observation that lysosomes are preferred targets for 
internalized nerve growth factor [24], the natural ligand of 
p75NTR, which might be mimicked by fluorochromated 
antibodies raised against p75NTR. 
Whereas the quenching of autofluorescence with Sudan 
Black B in the present work hardly affected the intensity of 
. 2 a . a j j g b g i i n g a n ( j subsequent immunofluorescence stain-
ing, strong autofluorescence might interfere with the 
identification of cholinergic neurons with Cy3-ME 20.4 in 
live brain slices originating from aged animals. 
Our present findings suggest the potential use of Cy3-ME 
20.4 in future neuropharmacological studies targeting the 
cholinergic system of higher mammals. Such investigations 
are also emphasized by the accelerated gathering of 
pharmacological data based on the • 2 a- a labeling of rat 
cholinergic basal forebrain neurons [11,12]. In particular, 
these studies showed that muscarinic receptor antagonists 
induce memory impairment due to a decrease of septo-
hippocampal GABA release, instead of the previously 
assumed diminished hippocampal acetylcholine release, 
and confirmed neuroanatomical data on collaterals of 
cholinergic neurons contacting parvalbumin-immunoposi-
tive GABAergic neurons within the MSDB [25]. 
CONCLUSION 
The high interspecies variability of the chemical nature, 
structure and topography of the cholinergic components in 
magnocellular BFB nuclei hampers the development of 
general functional concepts based on investigations of only 
one or a few animal species. Therefore, the use of ME 
20.4-saporin conjugates both in primates [16,17] and in 
sheep [19] suggests that Cy3-ME 20.4 might be successfully 
employed also in primates and ungulates, and become a 
useful cholinergic marker to determine morphological, 
electrophysiological and pharmacological parameters of 
cholinergic neurons under physiological or pathological 
conditions. 
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Excitotoxic lesions in the magnocellular nucleus basalis (MBN) lead 
to a significant damage of cholinergic neurons concomitant with in-
creased amyloid precursor protein (APP) expression in the cere-
bral cortex. However, the sensitivity of non-cholinergic neurons 
to excitotoxicity, and changes of APP expression in the damaged 
MBN are still elusive. Hence, we performed multiple-labeling 
immunocytochemistry for choline-acetyltransferase (ChAT), 
neuron-specific nuclear protein (NeuN) and APP 4, 24, and 48 h 
after NMDA infusion in the MBN. Whereas all cholinergic neurons 
were immunoreactive for NeuN, this neuronal marker also labeled 
a population of ChAT-immunonegative non-cholinergic neurons. 
Both neuron populations exhibited a similar degree of sensitivity 
to NMDA excitotoxicity that became evident as early as 4 h post-
lesion. Cholinergic MBN neurons showed abundant APP immuno-
reactivity (~90%), while only a fraction 20-30%) of non-choli-
nergic neurons expressed the protein. Remarkably, cholinergic but 
not non-cholinergic neurons retained their APP immunoreactivity 
after NMDA infusion. In conclusion, cholinergic MBN neurons 
are not preferentially sensitive to short-term excitotoxicity, 
but are one of the major sources of APP in the basal forebrain. 
NeuroReport 13.767-772 © 2002 Lippincott Williams & Wilkins. 
Key words: Basal forebrain; Choline-acetyltransferase; Confocal laser scanning microscopy; Excitotoxicity; In mo labeling; Neurodegeneration; 
Neuron-specific nuclear protein; Rat 
INTRODUCTION 
The basal forebrain (BF) complex of mammals consists of a 
confluent series of neuron populations that are anatomically 
subdivided in the medial septum, diagonal bands of Broca, 
and the magnocellular nucleus basalis (MBN) [1], Whereas 
BF neurons are substantially interconnected and form a 
diffuse neuronal network, their projections show a topolo-
gically defined distribution pattern with major output 
pathways to the hippocampus and cerebral cortex [2,3]. BF 
neurons exhibit a variety of neurotransmitter phenotypes, 
including magnocellular cholinergic, Ca2+-binding protein 
(CaBP)-containing GABAergic, glutamatergic and neuro-
peptidergic neurons [2,4,5]. The complex chemical neuroa-
natomy of the BF correlates with the diversity of brain 
functions these neurons modulate. 
Cholinergic BF neurons are critically involved in the 
modulation of learning and memory processing, and are 
among the severely affected neuron populations in Alzhei-
mer's disease (AD) [6,7]. Hence, the vast majority of recent 
neuropharmacological investigations focused on the sensi-
tivity, temporal profile of degeneration and eventual rescue 
of cholinergic BF neurons and their projections following 
noxious stimulation [7,8]. Cholinergic BF neurons were 
shown to be highly sensitive to excitotoxicity as was 
indicated by a robust loss of their marker enzyme choline-
acetyltransferase (ChAT) [9,10], while their survival was 
significantly enhanced by multiple neuroprotective com-
pounds [8,10,11]. In contrast, little is known about the 
reactivity of subpopulations of non-cholinergic BF neurons 
to neurotoxic insults. Although particular attention was 
directed towards the identification of a role for CaBPs in 
GABAergic interneurons, that may serve as a potential 
means to rescue nerve cells from Ca2 + overload associated 
with acute excitotoxicity [12,13], data are lacking as to 
whether acute excitotoxicity affects other non-cholinergic 
neuron populations in the BF complex. 
A central though still unresolved question in the 
pathogenesis of AD is the relationship of cholinergic 
breakdown and altered expression of the amyloid precursor 
protein (APP). Previous studies demonstrated that lesions to 
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BF nuclei elicit a rapid and persistent increase of APP 
expression in the cerebral cortex [14-16]. However, these 
studies solely focused on the temporal profile of APP 
expression and its cholinergic modulation in the cerebral 
cortex. 
Taking the above data together, in the present study 
we determined the number of cholinergic and non-
cholinergic neurons using multiple-labeling immuno-
cytochemistry under control conditions as well as 4, 24 
and 48 h after NMDA infusion in the MBN. Cholinergic 
neurons were identified by their immunoreactivity for 
ChAT and by in vivo labeling employing the fluorochro-
mated anti-p75 low-affinity neurotrophin receptor antibody, 
carbocyanine 3 (Cy3)-192IgG [9,17,18]. Neuron-specific 
nuclear protein (NeuN) was introduced as a pan-neuronal 
marker [19] to visualize neuronal perikarya irrespective of 
their neurotransmitter contents in the MBN. Moreover, APP 
immunoreactivity of the nerve cell populations, and its 
temporal changes under excitotoxic conditions were also 
investigated. 
MATERIALS A N D METHODS 
In vivo labeling: Young adult male Wistar rats (250-300 g, 
n~ 12; n = 4/group; bred at the University of Groningen) 
were caged individually and kept on a normal laboratory 
diet and tap water ad lib. All efforts were made to minimize 
animal suffering throughout the experiments. Their care 
and treatment were in accordance with the directives of the 
Local Ethical Committee of the University of Groningen 
(DEC 2493/2000). The rats were deeply anesthetized with 
isoflurane (2.0% (v/v%) in 70% N20/30% O^ 1.51/min flow 
rate) and their head position was secured in a stereotaxic 
frame (Narishige International, London, UK). For the in vivo 
labeling of BF cholinergic neurons 5 pi Cy3-192IgG (~1 mg/ 
ml in phosphate-buffered saline [PBS] 0.01 M, pH = 7.4) were 
injected slowly (0.5 (4l/min) into the right lateral ventricle 
(AP -1mm; L 1.5 mm; DV 3.2 mm) [20] with a Hamilton 
microsyringe. Cy3-192IgG was prepared by fluorochroma-
tion of pure 192IgG (3.5mg/ml, containing no additives; 
Dianova, Hamburg, Germany) with Cy3-N-hydroxysuccini-
mide ester using a FluoroLink-Antibody Cy3 Labeling Kit 
(Amersham Pharmacia Biotech., Freiburg, Germany), as 
described recently in detail [9]. 
NMDA infusion in MBN: Previous studies demonstrated 
that application of Cy3-192IgG does not alter either the 
electrophysiological or neurochemical properties of choli-
nergic neurons [9,17,18]. Therefore, 24 h later the rats were 
re-anesthetized with isoflurane, fixed in the stereotaxic 
apparatus and lp l NMDA (60 mM; Sigma, St. Louis, MO, 
USA) was injected in the right MBN (AP -1.5 mm; 
L 3.2 mm; DV 6.5 mm) [20] at an infusion rate of 0.1 jil/ 
min [9]. NMDA was freshly dissolved in PBS. As dissolving 
of NMDA considerably decreases the pH value of its 
vehicle, pH equivalent PBS (lpl; pH = 4.0) was used as 
control and injected in the contralateral (left) MBN of each 
animal in a manner identical to the NMDA infusion 
procedure. Short-term effects of NMDA infusion on MBN 
neurons were studied after a post-lesion delay of 4, 24, 
and 48 h. 
Immunocytochemical procedures: Fixation of the brains 
was carried out under deep sodium pentobarbital anesthe-
sia by transcardial perfusion with 350 ml fixative composed 
of 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 
7.4), which was preceded by a short pre-rinse (50 ml) with 
ice-cold physiological saline. Brains were post-fixed for 2 h 
in the same fixative and subsequently cryoprotected by 
overnight storage in 30% sucrose in PB at 4°C. Coronal 
sections were cut on a cryostat microtome at a 30 nm 
thickness and collected in PBS containing 0.1% sodium 
azide. 
Immunofluorescence labeling of APP, ChAT and NeuN 
was performed simultaneously on free-floating sections 
from all animals. All procedures started with extensive 
rinsing of the sections with 0.1 M Tris-buffered saline (TBS; 
pH 7.4) followed by blocking of non-specific binding sites 
for the subsequently applied immunoreagents with 10% 
normal donkey serum and 2% bovine serum albumin (BSA) 
in TBS containing 0.3% Triton X-100 (blocking solution; BS) 
for 1 h at room temperature. A first series of sections was 
double-stained for APP and NeuN by incubating the tissue 
in a mixture of goat anti-APP (1:40, raised against the amino 
acid sequence 45-62 of APP; AB 1593, Chemicon, Hofheim, 
Germany; according to [10]) and mouse anti-NeuN (1:100, 
MAB 377, Chemicon; [19]) primary antibodies in BS for 20 h. 
This was followed by the concomitant processing of the 
tissue with Cy2-conjugated donkey anti-goat and Cy3-
tagged donkey anti-mouse IgG. Both antibodies, as also all 
other highly purified fluorochromate immunoreagents 
applied in this study, were obtained from Dianova (Ham-
burg, Germany) as supplier for Jackson ImmunoResearch 
(West Grove, PA, USA), and used at a concentration of 
20 ng/ml in TBS containing 2% BSA (TBS-BSA) for 1 h at 
room temperature. In parallel, double labeling for ChAT and 
NeuN, as well as for ChAT and APP was performed 
employing rabbit anti-ChAT (1:400; AB 143, Chemicon) 
[9,17], mouse anti-NeuN (1:50) and goat anti-APP (1:20) 
primary antibodies that were diluted in BS and incubated 
overnight. Immunoreactivities were then visualized by 
applying appropriate mixtures of Cy3-conjugated donkey 
anti-rabbit IgG, Cy2-donkey anti-mouse IgG, or Cy2-donkey 
anti-goat IgG. Detection of NeuN as above was also 
combined with the red fluorescent immunostaining of 
ChAT, which stained all cholinergic neurons including 
those pre-Iabeled by Cy3-192IgG, and of APP. The sections 
were primarily incubated in a mixture of mouse anti-NeuN 
(1:50), rabbit anti-ChAT (1:400) and goat anti-APP (1:20) in 
BS overnight. Next, the immunoreactivities were revealed 
by applying a mixture of 7-amino-4-methylcoumarin-3-
acetyl (AMCA)-tagged donkey anti-goat IgG (30 ng/ml), 
Cy3-conjugated donkey anti-rabbit IgG and Cy2-coupled 
donkey anti-mouse IgG in TBS-BSA for 1 h. For the 
quadruple staining of Cy3-192IgG, ChAT, APP and NeuN, 
sections were exposed to a mixture of rabbit anti-ChAT 
(1:100), goat anti-APP (1:40) and mouse anti-NeuN (1:50) 
antibodies diluted in BS overnight. Extensively rinsed tissue 
was then reacted with a cocktail composed of AMCA-
conjugated donkey anti-rabbit IgG (30-40 pg/ml; TBS-BSA), 
Cy5-tagged donkey anti-goat IgG and Cy2-coupled donkey 
anti-mouse IgG for 1 h. In control experiments, omission of 
the primary antibodies yielded absence of any cellular 
labeling. Additional control experiments were performed 
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by switching the fluorophores related to the relevant 
cytochemical markers to confirm their labeling patterns. 
After all immunocytochemical procedures the sections were 
extensively rinsed in TBS, dipped in distilled water, 
mounted and coverslipped with Entellan (in toluene, Merck, 
Darmstadt, Germany). 
Quantification and statistical analysis: At least three 
sections spanning the intermediate MBN in each animal 
were used to investigate the effects of vehicle and NMDA 
infusions. The number of all immunoreactive neurons was 
determined in both the ipsilateral and contralateral MBN as 
described previously in detail [9]. Care was given not to 
include fragmented neuronal profiles. Total cell numbers for 
ChAT and NeuN were estimated using the disector formula 
as described elsewhere [21], The degree of co-localization of 
selected pairs of markers was determined in a semi-
quantitative fashion. To this end, double- or triple-labeled 
sections were employed and inspected using a Zeiss 
Axioplan fluorescence microscope equipped with appro-
priate double and triple band pass filters (Zeiss, Jena, 
Germany). Representative triple and quadruple-labeled 
sections were imaged with an LSM 510 confocal laser-
scanning microscope (Zeiss). 
The effect of NMDA lesions on the number of neurons, as 
well as on the degree of co-localization of the cellular 
markers at the particular post-lesion time points was 
statistically evaluated using paired t- test (SPSS for Win-
dows, release 10.0, SPSS Inc., Chicago, IL, USA). Significance 
was defined as an overall effect on the entire MBN region 
sampled, p < 0.05 was taken as indicative of statistical 
significance. Data were expressed as percentages and 
presented as means ± s.e.m. 
RESULTS 
Under control conditions, ChAT-immunoreactive (ir) mag-
nocellular neurons formed the well-known neuronal net-
work in the MBN (Fig. la, Fig. 2a), and were frequently in 
vivo labeled with Cy3-192IgG (Fig. lb) [9]. Quantitative 
analysis of ChAT-ir nerve cells 4, 24, and 48 h after vehicle 
infusion in the MBN revealed 2167 ± 383, 2531 ± 109 and 
2618 ± 294 neurons, respectively. All ChAT-positive neu-
rons also displayed NeuN immunoreactivity (Fig. lb, 
Fig. 2a). In contrast, only ~50% of NeuN-positive nerve 
cells were also immunoreactive for ChAT (Table 1). Thus, 
the population of NeuN-ir but ChAT-immunonegative MBN 
neurons corresponds with intermingled non-cholinergic 
neurons in the MBN. Accordingly, estimation of the number 
of NeuN-positive neurons in the sham-lesioned MBN 
indicated 4541 ± 434, 4441 ± 351 and 5071 ± 108 neurons 
4, 24 and 48 h post-surgery. The vast majority (~90%) of 
cholinergic MBN neurons exhibited APP immunoreactivity 
(Fig. lc, 2a", Table 1), whereas only a smaller fraction (20— 
30%) of non-cholinergic MBN neurons was immunoreactive 
for APP. NMDA infusion resulted in a massive loss of ChAT 
immunoreactivity that became apparent as early as 4 h post-
lesion and persisted throughout the survival period 
investigated (Fig. 2b-d). As Table 2 shows, a significant 
reduction of the ChAT-ir neuron population (cell numbers: 
1283 + 352, 4h; 885 ± 104, 24 h; 1236 ± 266, 48 h) was 
evident relative to the contralateral MBN. In parallel with 
the NMDA-induced cholinergic breakdown, the number of 
NeuN-ir neurons also exhibited a significant decline at each 
time-point investigated (cell numbers: 2407 + 361, 4h; 
2060 ±166, 24 h; 2656 ± 523, 48 h; Fig. 2b'-d, Table 2). 
Interestingly, NMDA infusion did not alter the ratio 
of ChAT-ir and NeuN-ir neurons in the damaged MBN 
(Table 1). Neuronal APP immunoreactivity displayed a 
similar temporal profile as the above markers with a 
significant decrement throughout the post-lesion interval 
investigated (Table 2). It is worth noting that more than 90% 
of the cholinergic neurons withstanding NMDA excitotoxi-
city also retained their APP immunoreactivity (Fig. 2d"; 
Table 1)- On the other hand, the ratio of NeuN-positive/ 
APP-ir nerve cells declined after NMDA infusion, reaching 
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Fig. I. A series of confocal laser-scanning microscopy images of an in vivo-labeled cholinergic neuron immunoreactive for amyloid precursor protein 
(APP) in rat nucleus basalis under control conditions. Pairs of color-coded images were obtained following quadruple immunolabeling for APP. Cy3-
l92lgG, neuron-specific nuclear protein (NeuN), and choline-acetyltransferase (ChAT). NeuN.ChATand APP were revealed with Cy2 (green), AMCA 
(blue, a) and Cy5 (color-coded in purple) respectively, while Cy3-l92lgG appears in red (b).The concomitant appearance of Cy3-l92lgG and APP (color-
coded in purple; c) denotes constitutive APP expression of cholinergic projection neurons in the nucleus basalis. Bar = 40 pm. 
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Table I. Cellular co-localization of neuron-specific nuclear protein (NeuN), choline-acetyltransferase (ChAT) and amyloid precursor protein (APP) 
immunoreactivities 4, 24, and 48 h after NMDA infusion in the rat magnocellular nucleus basalis (MBN). 
Time (h) Hemisphere NeuN'/ChAT' (%) ChAT'/APp- (%) NeuN'/APP" (%) 
4 Sham lesioned 53.7 + 10.5 90.1 +2.2 56.4+4.4 
NMDA lesioned 40.2+15.0 93.6+4.3 49.7+4.2 
24 Sham lesioned 46.2+4.9 95.1 ±1.0 49.6+7.1 
NMDA lesioned 40.7 + 10.5 90.1 +2.8 25.9 + ll.l 
48 Sham lesioned 48.1 ±7.5 94.5 + 1.7 79.5+4.7 
NMDA lesioned 45.3 + 10.8 91.8+2.7 64.6 + 6.9 
NMDA infusion in the MBN did not influence the percentage co-localization of the cellular markers investigated, compared to sham-operated conditions at 
any of the post-lesion time-points investigated. Co-localization of each pair of the cellular markers was determined using a Zeiss Axioplan fluorescence 
microscope fitted with appropriate double band pass filters for the concomitant detection of immunosignals. Data are expressed as means ± s.e.m. 
(n = 4/group). 
Table 2. Short-term effect of NDMA infusion in the magnocellular nucleus basalis (MBN) on the loss of neuron-specific nuclear protein (NeuN), choline-
acetyltransferase (ChAT) and amyloid precursor protein (APP) immunoreactivities. 
Time (h) ChAT* (% loss of neurons) NeuN * (% loss of neurons) APP ' (% loss of neurons) 
4 42.0 + 8.4« 474+5.7** 52.6+6.4** 
24 65.1 +3.9« « 52.5+7.5* 51.8+16.8* 
48 54.4 +8.1 «« 46.9+11.9* 56.8+3.6** 
The number of nerve cells immunoreactive for NeuN, ChATor APP was determined in both the sham- and NMDA-lesioned MBN 4, 24 and 48 h post-surgery. 
The relative value of cell loss for each cellular marker was calculated as the percentage difference between the numbers of immunoreactive neurons at 
NMDA- and sham-lesioned sides of the brain.The cell counting protocol is referred to in Materials and Methods. Statistically significant differences between 
the NMDA-lesioned and control MBN at particular post-lesion time-points: **p < 0.01, *p < 0.05 (paired t-test). Data are expressed as means ± s.e.m. 
(rl = 4/group). 
maximum 24 h post-lesion (25.9 + 11.1%, Table 1), that 
points to a marked loss of APP immunoreactivity of non-
cholinergic MBN neurons. 
It is noteworthy that APP immunoreactivity was observed 
in neural structures that were immunonegative for both 
ChAT and NeuN following NMDA infusion in the MBN 
(Fig. 2b"-d"). The progressive post-lesion appearance of this 
immunoreactivity suggests a glial origin for such APP 
labeling [10]. 
DISCUSSION 
Major novel findings of the present study include that all 
cholinergic MBN neurons are positive for NeuN, while 
double-immunofluorescence labeling with ChAT and NeuN 
can also be utilized to visualize non-cholinergic nerve cells 
in the basal forebrain. Interestingly, the ratio of NeuN and 
ChAT co-localization was ~50%. The NeuN-Iabeled non-
cholinergic neuron population of the MBN was as sensitive 
to acute excitotoxicity as the cholinergic neurons when 
exposed to 60 mM NMDA. The majority of cholinergic 
neurons express APP both under control and acute 
excitotoxic conditions. In contrast, a smaller percentage of 
NeuN-ir non-cholinergic neurons exhibits APP immuno-
reactivity under physiological circumstances that further 
decreases shortly after exposure to NMDA. 
BF nuclei comprise neurons with a broad neurochemical 
heterogenity. Whereas the absolute numbers of cholinergic 
neurons under control conditions detected in our study 
corroborate previous data [21-23], the amount of NeuN-ir 
nerve cells seems relatively low based on the assumption 
that NeuN can be utilized as a general neuronal marker [19]. 
Previous studies of ours [21 ] and others [23] point to total 
cell numbers in the MBN a magnitude higher than those 
detected by NeuN. Hence, we assume that the BF, similar to 
e.g. the cerebellum [19], contains neurons that are immu-
nonegative for NeuN. To this end, NeuN staining can be 
regarded as a useful marker to tag subpopulations of BF 
neurons. Further studies are yet to be performed to reveal 
the neurochemical nature of NeuN-ir non-cholinergic, as 
well as of NeuN-immunonegative nerve cells. 
The loss of NeuN-ir non-cholinergic neurons paralleled 
the decline of cholinergic nerve cells after the NMDA-
induced excitotoxic challenge. The similarly reduced num-
bers of neurons reactive for NeuN or ChAT supports this 
conclusion (Table 2) concomitant with the preserved ratio of 
co-localization of the two neuronal markers (Table 1) 
throughout the post-lesion period investigated. In func-
tional terms, the simultaneous loss of ChAT and NeuN 
Fig. 2. Short-term effects of NMDA excitotoxicity on distinct neuron populations in rat magnocellular nucleus basalis (MBN).The triple immunofluor-
escence labeling for choline-acetyltransferase (ChAT, a - d ) , neuron-specific nuclear protein (NeuN. a ' - d ' ) , and amyloid precursor protein (APP, a"-d") 
allowed visualization of distinct subpopulations of MBN neurons. The immunocytochemical markers were captured by confocal laser-scanning micro-
scopy and color-coded as follows: ChAT in red (Cy3). NeuN in green (Cy2) and APP in blue (AMCA). Structures co-expressing the three cellular markers 
appear white (arrows). Whereas a dense network of cholinergic and intermingled non-cholinergic neurons was seen under control conditions (a-a"), 
excitotoxic damage to both cholinergic and non-cholinergic subpopulations of MBN neurons became evident at 4 h post-lesion (b-b") and was present 
throughout the survival periods investigated (c-c", d-d"). Note the enhanced APP immunoreactivity at the different post-lesion time-points (b",c",d"), 
compared to controls (a"). Arrowhead in d" points to a cholinergic MBN neuron with low APP immunoreactivity. Bar = 50 pm. 
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immunoreactivities suggests that at least a subset of non-
cholinergic neurons is as sensitive to acute excitotoxicity as 
cholinergic nerve cells. As neurons expressing different 
CaBPs were present 4 and 24 h after NMDA infusion in the 
MBN (Hártig Wand Harkany T, unpublished observations), 
we presume that glutamatergic or peptidergic neurons 
might form the non-cholinergic neuron population that is 
sensitive to NMDA excitotoxicity. It remains to be eluci-
dated, however, whether the response of cholinergic and 
distinct non-cholinergic MBN neurons to NMDA excito-
toxicity is similar as a function of increasing NMDA 
concentration. 
It is a widely accepted phenomenon that cholinergic 
activity directly modulates APP expression in the brain 
[14-16,22], and vice versa, that constitutive APP over-
expression leads to the reorganization of cortical cholinergic 
terminals [24], It remains elusive, however, whether the 
increased APP concentration in the cerebral cortex after 
subcortical cholinergic denervation [14,15] is due to the 
temporary overt APP expression of degenerating choliner-
gic and/or non-cholinergic cortical projections, represents a 
sustained post-synaptic response (e.g. hypersensitivity), or 
both. Our data on APP immunolabeling demonstrate that 
cholinergic MBN neurons abundantly express APP both 
under control, as well as under excitotoxic conditions. 
Previous studies utilizing longer survival periods [10] 
demonstrated that severely damaged, and probably apop-
totic, MBN neurons exhibit significantly increased APP 
immunoreactivities, whereas those withstanding the excito-
toxic challenge are only moderately labeled. Remarkably, 
the majority of NeuN-ir non-cholinergic MBN neurons 
appeared to be APP-immunonegative, and a decrease of 
their APP immunoreactivity was demonstrated after 
NMDA infusion. These observations together with the fast 
anterograde transport of APP in neuronal projections [25] 
indicate that cholinergic neurons in the BF, abundantly 
express APP and may play a primary role in regulating the 
cortical APP load after BF lesions. 
CONCLUSIONS 
The parallel decline of ChATand NeuN immunoreactivities 
after NMDA infusion demonstrates that a subset of non-
cholinergic neurons exists in the rat MBN that is sensitive to 
acute excitotoxic injury to a degree comparable to that of 
cholinergic nerve cells. From a methodological point of view 
it is noteworthy that ~ 4500-5000 neurons were immuno-
reactive for NeuN in the MBN. As previous findings [21,23] 
suggest significantly higher numbers of neurons in the 
MBN, further studies are awaited to determine whether 
NeuN only labels a subset of BF neurons, or Nissl staining-
based quantification protocols overestimated the number of 
nerve cells in the rat BF. Our neuroanatomical data also 
indicate that cholinergic neurons can be regarded as one of 
the major sources of APP in the BF under both control and 
pathological conditions. In contrast, only a limited portion 
of NeuN-ir non-cholinergic neurons is APP immunoreactive 
that further decreases after exposure to NMDA. Taking the 
rapid increase of cortical APP expression after MBN lesions 
into account [14,15], it seems likely that excess production of 
APP by cholinergic BF neurons and subsequent fast axonal 
transport of APP to the cerebral cortex [25] might be in 
causal relationship with the cortical changes of APP 
concentrations. 
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